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Abstract 
The systematic process of skin cells regeneration can be affected of several factors 
causing an abnormal grow of new cells. The excess of cells may form a mass of tissue called 
neoplasm. The neoplasm may be benign or malignant. Benign neoplasms rarely require 
treatment, just periodic checkups are recommended to control and to ensure that they do 
not evolve into malignancy. Within the malignant neoplasms, the most relevant are 
melanoma, basal cell carcinoma and squamous cell carcinoma which have effective 
treatments. Contrary, malignant melanoma can only be remised with an aggressive treatment 
in an early phase. According World Health Organization (WHO), the incidence of this type of 
cancer in the European Union (27 countries) are 12.2 persons per 1M inhabitants, the 
mortality is approximately 2.2 persons, and the prevalence at 1st, 2nd and 3rd years are 12 %, 
34.1 % and 53.9 % respectively. Thus, it is necessary to find new cost-effective tools that can 
contribute to early diagnosis or treatment assessment. Medical thermography is a non-
invasive, non-ionizing, non-contact and reliable medical imaging method, which allows 
monitoring the temperature distribution on the skin surface. This information is directly 
related to the physiology, enabling a real-time monitoring, especially in peripheral 
microvascular and autonomous nervous systems.  
This study aims to use the medical thermography for physiological characterization of skin 
neoplasms. It is a retrospective and explorative study consisting of a control group and a 
group of malignancy holders. Skin surface temperature was characterized according to the 
dermatomes location of the autonomous nervous system and main blood vessels location of 
the microvascular system. The relationship of these characteristics with the type of recurrent 
skin neoplasms was assessed.  
It was possible to characterize the temperature of skin neoplasms, facilitating early 
diagnosis, targeting adequate treatments and a substantial reduction of associated costs. 
 
 
Keywords: Medical thermography; Monitoring; Skin cancer; Skin surface temperature; Skin 
neoplasms.  
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Resumo 
O processo sistemático de regeneração das células da pele pode ser afetado por vários 
fatores causando um crescimento anormal de novas células. Esse excesso pode formar uma 
massa de tecido designada por neoplasia (benignas ou malignas). As benignas raramente 
necessitam de tratamento, apenas são recomendados exames periódicos para controlo, de 
forma a garantir que não evoluem para malignas. Das neoplasias malignas destacam-se os 
melanomas, os carcinomas basocelulares e os espinho-celulares. Os carcinomas basocelulares 
e espinocelular são os mais comuns, tendo um tratamento bastante eficaz. Pelo contrário, o 
melanoma apenas pode entrar em remissão, com um diagnóstico precoce e tratamento 
agressivo. A incidência deste tipo de neoplasia na União Europeia – 27 países (UE27) é de 12.2 
pessoas por 100000 habitantes, a mortalidade cerca de 2.8 pessoas e a prevalência no 1º, 2º e 
3º ano é de 12%, 34.1% e 53.9% respetivamente.  
Assim sendo, é necessário encontrar novas ferramentas que contribuam para um 
diagnóstico precoce ou avaliação de tratamento e que sejam financeiramente atrativas. A 
termografia médica é um método de imagem clínica não invasivo, não ionizante e preciso, 
que permite monitorizar a distribuição da temperatura à superfície da pele. Esta informação 
está diretamente relacionada com a fisiologia, permitindo a sua monitorização em tempo 
real, nomeadamente dos sistemas microvascular periférico e nervoso autónomo.  
Esta investigação teve como finalidade utilizar esta técnica para avaliação fisiológica, 
caracterizando as lesões neoplásicas da pele. Trata-se de um estudo retrospetivo e 
explorativo constituído por um grupo de controlo e indivíduos detentores de neoplasias. 
Usando a termografia de forma padronizada, caracterizou-se a temperatura à superfície da 
pele de acordo com a localização dos dermatomas do sistema nervoso autónomo, e com a 
localização dos vasos sanguíneos principais do sistema microvascular de cada indivíduo. 
Avaliou-se também a possível relação destas características com o tipo de neoplasia 
recorrente nos indivíduos.  
Foi possível caracterizar a temperatura das neoplasias, facilitando o diagnóstico 
atempado, tratamento direcionado e uma redução substancial dos custos associados a estas 
patologias. 
 
Palavras-chave: Cancro de pele , Monitorização, Neoplasias de pele, Termografia 
médica, Temperatura superficial da pele.   
viii 
  
ix 
Acknowledgments 
To my parents and brother for all the encouragement and support in all my choices and 
decisions.  
 
To my best friend and boyfriend, João Ribeiro, for all patience, help, care, love and 
strength in these difficult times. With you I can go further and topple giants, being more than 
I had ever imagined. 
 
To my friends, in special Ana Marques, for their friendship and for being always by my 
side, giving me words of comfort and encouragement. 
 
To my supervisor Ricardo Vardasca and, the head of the Laboratory of Automation and 
Instrumentation in Biomedicine at FEUP, Prof. Joaquim Gabriel for the teaching and 
knowledge transmitted. 
 
To Dr. Marco Rebelo and Matilde Ribeiro for all of the support and for making it possible 
to put this study in practice at IPO-Porto. 
 
To all the volunteers of Porto University and IPO-Porto who showed willingness to take 
part in this study. 
 
  
x 
 
xi 
Contents 
Abstract ......................................................................................................... v 
Resumo ......................................................................................................... vi 
Acknowledgments.......................................................................................... viii 
List of figures ................................................................................................ xii 
List of tables ................................................................................................ xiv 
Abbreviations and Symbols .............................................................................. xvi 
 
 
Chapter 1. ...................................................................................... 1 
1.1 Introduction .................................................................................................. 1 
1.2. Aim ........................................................................................................... 2 
1.3. Dissertation Outline ....................................................................................... 3 
Chapter 2. ...................................................................................... 6 
2.1 Human skin ................................................................................................... 6 
2.1.1 The role of the skin in thermoregulation ......................................................... 7 
2.1.2 Anatomy of nerves, arteries and veins of the face .............................................. 8 
2.1.3 Skin Neoplasms ...................................................................................... 10 
2.2 Thermology ................................................................................................. 14 
2.2.2 Medical Thermography ............................................................................. 16 
2.2.3 Non-invasive competing techniques ............................................................. 23 
2.3 Summary considerations ................................................................................. 24 
Chapter 3. ..................................................................................... 26 
3.1 Equipment .................................................................................................. 26 
3.2 Sample Characterization ................................................................................. 27 
3.3 Data collection protocol ................................................................................. 31 
3.4 Inclusion and exclusion criteria ........................................................................ 34 
3.5 Analysis protocol .......................................................................................... 34 
3.5.1 Control group analysis .............................................................................. 35 
3.5.2 Diagnosed and Follow-up group analysis ........................................................ 36 
xii 
3.5.3 Case-study ............................................................................................ 37 
3.6 Statistical treatment ..................................................................................... 37 
Chapter 4. ..................................................................................... 40 
4.1 Skin surface temperature characterization .......................................................... 40 
4.1.1 Control Group ........................................................................................ 40 
4.1.2 Oncologic Group ..................................................................................... 44 
4.2 Individuals characteristics and skin temperature ................................................... 46 
4.2.1 Control Group ........................................................................................ 46 
4.2.2 Oncologic Group ..................................................................................... 52 
4.3 Individuals characteristics and malignancy .......................................................... 54 
4.4 Case Study – Basal cell carcinoma ..................................................................... 56 
4.5. Summary considerations ................................................................................ 57 
Chapter 5. ..................................................................................... 58 
5.1 Skin surface temperature characterization .......................................................... 58 
5.2 Individual characteristics and skin temperature .................................................... 60 
5.3 Individuals characteristics and malignancy .......................................................... 61 
5.4 Case studies ................................................................................................ 62 
Chapter 6. ..................................................................................... 64 
6.1 Proposed future work .................................................................................... 64 
References .................................................................................... 66 
APPENDIXES ................................................................................... 72 
Appendix I: Approved ethics Committee document ..................................................... 72 
Appendix II: Volunteers information ....................................................................... 73 
Appendix III : Consent Form ................................................................................. 76 
Appendix IV : Questionnaire ................................................................................. 77 
APPENDIXE V: ANS results of p-value and ranking values to right side of each phase ............. 80 
APPENDICE VI: ANS mean temperatures to left side of each phase and results of p-value 
and ranking values ..................................................................................... 81 
Appendix VII: MS mean temperatures to right side of each gender and results of p-value 
and U,W an Z values ................................................................................... 82 
Appendix VIII: MS mean temperatures to left side of each gender and results of p-value 
and U,W an Z values ................................................................................... 84 
Appendix IX: MS thermal symmetry of each gender and results of p-value, U,W and Z 
values..................................................................................................... 86 
Appendix X: MS mean temperatures of right side of each phase and results of p-value, 
U,W and Z values ....................................................................................... 88 
Appendix XI: MS mean temperatures of left side of each phase and results of p-value, U,W 
and Z values ............................................................................................. 90 
Appendix XII: MS thermal symmetry of each phase and results of p-value, U,W and Z 
values..................................................................................................... 92 
 
xiii 
List of figures 
Figure 1: Dissertation Outline. .............................................................................. 4 
Figure 2: Different layers of the skin, dermis, epidermis and constituents cells .................. 7 
Figure 3: Processes of vasodilatation and vasoconstriction in different environments. .......... 8 
Figure 4: Dermatome distribution of the trigeminal nerve ............................................. 9 
Figure 5: Superficial arteries and veins of face and scalp .............................................. 9 
Figure 6: Different types of benign skin neoplasms ................................................... 10 
Figure 7:Different types of malignant skin neoplasms ................................................ 11 
Figure 8:Differences between benign and malignant neoplasms relatively to ABCD analysis .. 13 
Figure 9:Frequency and wavelength of the electromagnetic spectrum . .......................... 15 
Figure 10: Thermography of woman face in two different positions. .............................. 17 
Figure 11: Equipment for capturing thermographic images .......................................... 27 
Figure 12: Composition of the population proportions of each group. ............................. 27 
Figure 13: Room humidity distribution in both groups. ............................................... 28 
Figure 14: Room temperature distribution in both groups. .......................................... 28 
Figure 15: Type of neoplasm prevalence in both groups ............................................. 30 
Figure 16: Skin neoplasm location prevalence in both groups ....................................... 31 
Figure 17: Cold stimulation and recovery collection protocol for three different moments. .. 33 
Figure 18: Thermograms of control group in three different moments of frontal and right 
profile .................................................................................................34 
Figure 19: Frontal and profile images with the selected ROIs ....................................... 35 
Figure 20: Regions of interest of ANS and MS ........................................................... 36 
Figure 21: ROI selection on skin neoplasm group ...................................................... 36 
Figure 22: ROI selection in control individual and basal cell carcinoma individual .............. 37 
Figure 23: Temperature differences between moments regarding ANS of ROI's. ................ 41 
Figure 24: Temperature differences between moments regarding MS of three ROI's. .......... 43 
Figure 25: ΔT values of the benign and malign skin neoplasms in both groups of noplasm. ... 45 
Figure 26: ΔT values of the different type of skin neoplasms in the differences groups. ...... 46 
Figure 27: Thermographic and visual images of some skin neoplasms. ............................ 46 
Figure 28: Illustration of the malignancy prevalence with family history. ........................ 56 
xiv 
Figure 29: ΔT illustration in the different case studies. .............................................. 56 
Figure 30: Example of diagonals on skin neoplasm. ................................................... 60 
xv 
List of tables 
Table 1: Melanoma incidence rate in the 5 countries with more pathology prevalence .......... 1 
Table 2:Different diagnosis techniques and treatment options to the various types of skin 
cancer .................................................................................................... 14 
Table 3:Thermal symmetry of some ROIs using Medical Thermography ........................... 23 
Table 4: General specifications of each group in terms of mean and standard deviation. ..... 29 
Table 5: Description of the inclusion and exclusion criteria of this study. ........................ 34 
Table 6: Description of mean distribution equality tests. ............................................ 38 
Table 7: Mean temperature characterization of the right side in each moment, and the 
corresponding p-values of Wilcoxon test. .......................................................... 40 
Table 8: Mean temperature characterization of ROIs left side in each moment. Are also 
showed the corresponding p-values of Wilcoxon test............................................ 41 
Table 9: ROIs thermal symmetry in each moment and the corresponding p-values of Wilcoxon 
test........................................................................................................ 42 
Table 10 : Mean temperature characterization of ROIs right side in each moment and the 
corresponding p-values of Wilcoxon test. .......................................................... 42 
Table 11: Mean temperature characterization of the left side in each moment and the 
corresponding p-values of Wilcoxon test. .......................................................... 43 
Table 12: ROIs thermal symmetry in each moment and the corresponding p-values of Wilcoxon 
test........................................................................................................ 44 
Table 13: Characterization of median temperature values of skin neoplasms in both groups. 44 
Table 14: Description of U Mann-Whitney test results for the ΔT comparison.................... 45 
Table 15: Mean temperatures to the right side of each gender for three different moments. 47 
Table 16: Results of p-value, U, W and Z values of U Mann Whitney test between moments for 
the right side. ........................................................................................... 47 
Table 17: Mean temperatures to the left side of each gender for three different moments. . 48 
Table 18: Results of p-value, U, W and Z values of U Mann Whitney test between moments for 
the left side. ............................................................................................ 48 
Table 19: Mean temperatures to the thermal symmetry of each gender for three different 
moments. ................................................................................................ 49 
Table 20: Results of p-value, U, W and Z values of U Mann Whitney test between moments for 
thermal symmetry. ..................................................................................... 49 
Table 21: Mean temperatures to right side of each phase for three different moments. ...... 50 
Table 22: Mean temperatures to thermal symmetry of each phase for three different 
moments. ................................................................................................ 50 
xvi 
Table 23: Results of p-value, U, W and Z values of U Mann Whitney test between moments for 
thermal symmetry. .................................................................................... 51 
Table 24: Obtained results for each characteristic to median temperatures of aright and lefts 
sides and ΔTs for diagnosed group. ................................................................. 53 
Table 25: Results follow-up group characteristic to right and lefts sides and ΔT. ............... 53 
Table 26: U Mann Whitney test results in terms of p-value and ranking values for diagnosed 
group. .................................................................................................... 54 
Table 27: Kruskal-wallis test results in terms of p-value for diagnosed group. .................. 54 
Table 28: U Mann Whitney test results. ................................................................. 54 
Table 29: Kruskal-wallis test results in terms of p-value. ............................................ 54 
Table 30: Prevalence of malignancy by age classes. .................................................. 55 
Table 31: Prevalence of malignancy in gender. ........................................................ 55 
Table 32: Prevalence of malignancy by BMI classes. .................................................. 55 
Table 33: Prevalence of malignancy by sun sensibility classes. ..................................... 55 
Table 34: Results of U Mann-Whitney test. ............................................................. 57 
 
xvii 
Acronyms and Symbols 
ANS  Autonomous Nervous System 
BMI  Body Mass Index 
FEUP Faculdade de Engenharia da Universidade do Porto 
IPO-Porto Instituto Português de Oncologia do Porto 
ITI  Intraoperative Thermal Imaging 
MS  Microvascular System  
ROIs Regions of Interest 
TS  Thermal symmetry 
ΔT   Temperature difference between the left and the right side of skin  
  neoplasms 
U  U-Mann Whitney  
W  Wilcoxon W 
Z  Wilcoxon Z 
  
Chapter 1.  
1.1 Introduction 
Skin neoplasms are an abnormal mass of tissue that results from an abnormal growth, or 
cell division. There are two types of skin neoplasms, benign and malignant, also called skin 
cancers. 
A benign neoplasm is localized, manifests itself by growing above the skin surface, does 
not invade adjacent tissues, does not spread to other parts of the body, and can easily be 
removed, rarely puts the patient’s life at risk. On the other hand, the malignant neoplasm 
presents an uncontrolled growth of abnormal skin cells. This situation occurs when unrepaired 
DNA damaged skin cells (most often caused by ultraviolet radiation from sunshine or tanning 
beds), triggers mutations, or genetic defects, which lead the skin cells to multiply rapidly. 
The main types of skin malignant neoplasms are: basal cell carcinoma and squamous cell 
carcinoma (non-melanoma skin cancer) and melanoma [1]. Table 1 shows the countries that 
have a higher incidence of skin cancer: Australia, New Zeeland, Switzerland, Denmark and 
Norway [2]. 
Table 1: Melanoma incidence rate in the 5 countries with more pathology prevalence [2]. 
Country Skin cancer incidence rate (1 to 100000) 
Australia 36.7 
New Zeeland 36.2 
Switzerland 25.8 
Denmark 24.1 
Norway 25.3 
Portugal 8.2 
UE27 13 
The incidence of both, non-melanoma and melanoma skin cancer, has been increasing 
over the past decades. Currently, between 2 and 3 million non-melanoma skin cancers and 
132 thousands melanoma skin cancers occur globally each year. Basal cell carcinoma is the 
most common form of skin cancer and the squamous cell carcinoma is the second. Melanoma 
is generally the most serious form of malignant neoplasms because it tends to spread 
(metastasize) throughout the body quickly. According to the American Cancer Society, one 
person dies of melanoma approximately every hour [5]. 
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In Portugal, there are about 700 new cases of melanoma annually [3]. The incidence of 
this type of cancer in the European Union of 27 countries (EU27) is of 13 persons per 100000 
people, the mortality is approximately 2.2 persons, and the prevalence at 1st year is 12%, in 
the 2nd year is 34.1% and finally, in the 3rd year is 53.9% respectively [3, 4]. 
This year an estimated of 76100 new cases of invasive melanoma will be diagnosed in the 
United States and 9710 people will die of melanoma [5]. 
In United States, the cost of skin cancer treatment varies, depending on the size, type, 
depth and location of the lesions, and, most important, the stage in which it was detected. 
One study published in the Archives of Dermatology found average treatment costs for skin 
cancers to range from 1732 to 56059 United States Dollars (USD) depending on the stage of 
the disease [6]. The costs associated with melanomas treatment exceed USD 740 million 
annually [7]. In 2009, the average monthly cost per patient with melanoma was 
approximately about USD 2194 during the first four months of treatment. For people aged 65 
or older, the annual cost was around USD 390 million [8, 9].  
Australia is the country in the world with the highest incidence of melanoma patients. 
Every year, 10430 new cases are identified. The costs associated with cancer in this country 
are of 3.8 billion Australian Dollars (AUD) per year in direct costs of health care. Worrying is 
the fact that only 1% (AUD 30 million) are spent on treatments of melanomas [8]. Non-
melanoma skin cancers have cost to the Australian health system more than AUD 500 million 
in 2010 and are expected to cost AUD 700 million by 2015. 
Medical Thermography is an imaging technique that allows mapping the thermal radiation 
emitted by the surface of the human body skin, which under some conditions may reflect 
abnormal or normal situations of human physiology. Thermography is technique a non-
invasive, non-contact, non-ionizing and therefore safe for the patients. This technique is 
passive, and relies on the registration of the thermal radiation emitted by the surface of the 
skin from various parts of the body through a set of appropriate sensors that create an image 
of the surface temperature. The capture protocol recommended for medical thermography 
defines the environment in which an examination should be performed; the ambient 
temperature should be between 18 and 24 °C, relative humidity be less than 50%, the air flow 
should be less than 2 m/s and there should be absence of light incident upon the subject [10–
12].  
 
1.2. Aim 
This work aims to investigate the use of medical thermography for physiological 
assessment, characterization and monitoring skin neoplasms in several areas of the body, on 
IPO patients. 
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Two different studies will be made. The first has the objective to characterize the 
temperature of skin surface in asymptomatic individuals, based on dermatomes distribution 
of the Autonomous Nervous System (ANS) and in the perforated blood vessels of the 
Microvascular System (MVS), and their relationships with individual’s characteristics. In this 
group a wind stimulus (fan) will be applied during a period of two minutes, in order to 
evaluate the physiological response of the face. Thus, it was possible to perform a 
characterization study of the skin surface temperatures of the two systems (ANS and MVS). 
The second study, will be focused on the characterization of the skin surface temperature 
in patients with various skin neoplasms (benign or malign) and individuals who have already 
undergone in treatment. It will also be evaluate the relationship between individual’s 
characteristics and skin neoplasms type. In addition, a comparison case study will be 
performed with basal cell carcinoma individuals and a control group with similar BMI and 
gender. 
The results of this research will enable improvements in early diagnosis of skin 
neoplasms, targeting adequate therapies, and leading to a reduction of these pathologies 
associated costs. 
 
1.3. Dissertation Outline 
This document is organized in six sections. The first introduces the topic and 
characterization of the problem and its context. The literature review describes additional 
information found in the literature, which is relevant for the present work. The third section, 
outline the materials and methods used during this research. The fourth section presents the 
results for each experiment. In the fifth section, there is a discussion and analyzes of the 
significance of the obtained results. Finally, the conclusion addresses the final considerations 
and main achievements, as well as the future work. The structure of the dissertation and the 
links between different parts of this document can be seen in figure 1.  
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Figure 1: Dissertation Outline. 
  
  
Chapter 2.  
Literature review 
As a start, it is important to understand the anatomy of the skin, nerves, arteries and 
veins, the role of skin in thermoregulation, and the neoplasms associated with this part of the 
body. It is also necessary to understand their risk factors, treatment and diagnosis. Skin 
Neoplasm is a lump or growth that is formed from abnormal cells. 
Thermology is the science that studies temperature and its exchange process. It covers all 
thermal energy transfer processes such as: heating or cooling. Thus, this encompasses how 
heat can be exchanged between objects, as well as the features that this process involves. 
Within this chapter and together with these concepts, a brief introduction of thermography 
and its physical principles, history and applications in medicine are addressed. The 
alternative techniques to thermography are also outlined. 
2.1 Human skin 
The skin is the outer layer of the human body, and his biggest organ, with over 2 m2. This 
extensive area has external environment interaction like sun exposure, resulting on a 
excessive water loss and insulation [10]. It is composed of a complex structure system:  
dermis, epidermis and hypodermis [13–15]. The skin possesses, per cm2, about 650 sweat 
glands, 20 blood vessels, over a thousand hair follicles, half a million melanocytes, more than 
a thousand nerve endings, and also sebaceous glands [10]. 
The skin protects the body from heat, injury and infection, as well as damage caused by 
UV radiation from the sun. It stores water and fat, which participates in homeostasis, and 
plays an important role in thermoregulation [16–18]. 
The epidermis is the outer layer of the skin, composed mostly of squamous cells on the 
top and basal cells and scattered melanocytes on the bottom. Melanocytes are responsible for 
melanin production, the main pigment responsible for skin colour. When the human body is 
exposed to UV radiation, melanocytes acquire pigmentation, becoming darker [10, 11, 17, 
19]. 
The dermis is the layer under the epidermis, thicker than the latter. The main 
components of this layer are collagen and elastin fibers. The dermis contains various types of 
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cells, such as blood vessels, lymphatic vessels and glands. Some of these glands are 
responsible for the production of sweat, which allows the human body to cool down.  
Others produce sebum, which helps keep the body dry. Both reach the surface of the skin 
through little orifices named pores [10, 13, 17, 19]. Figure 2 shows the different layers of 
skin, namely epidermis and dermis. 
 
 
Figure 2: Different layers of the skin, dermis, epidermis and constituents cells [13]. 
2.1.1 The role of the skin in thermoregulation 
Thermoregulation is the ability of an organism to maintain its core body temperature 
when the temperature of the surrounding environment is different [14]. When the core body 
temperature increases significantly, it is called hyperthermia, when the opposite occurs it is 
called hypothermia. The thermoregulation process maintains the core body temperature 
unchanged, within a constant range, varying only about 0.6ºC, even when the organism is 
exposed to major cold or heat variations [21]. 
Thermoregulation is performed by a physiological control system, consisting of the central 
nervous system and peripheral thermoreceptors, an afferent conduction system, a central 
control for the integration of thermal impulses and an efferent response system which leads 
to compensatory responses [21].  
 The hypothalamus lies at the central nervous control system (brain) and regulates the 
body core temperature by integrating thermal impulses coming from peripheral 
thermoreceptors. The hypothalamus receives inputs from two sets of thermoreceptors, 
receptors which monitor the temperature of the blood that goes through the brain, and skin 
receptors, which monitor exterior temperature. Both supply the necessary information for 
the body to make appropriate adjustments. When the integrated impulse exceeds or falls 
below the temperature range, autonomic thermoregulatory responses happen in order to 
maintain appropriate body temperature. 
Due to skin relationship with the circulatory system, skin vessels dilate whenever the 
temperature rises above the expected, favouring heat exchange with the environment. This 
process is called vasodilation. Vasoconstriction is the opposite of vasodilation. In case of the 
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latter, the blood vessels narrow as a result of the contraction of the vessels' muscle wall, in 
particular, major arteries and small arterioles in response to a cold environment. 
Figure 3 shows the vasodilation and vasoconstriction processes, when in a hot or cold 
environment.  
 
Figure 3: Processes of vasodilatation and vasoconstriction in different environments, on the left cold environment, 
on the right warm environment [22]. 
Muscle contractions also act in the regulation of body temperature allowing heat 
recovering by increasing the internal body temperature. Another characteristic of the human 
skin is its ability to produce sweat or perspiration, which leads to a rapid temperature 
decrease [21]. 
Energy transfer by evaporation occurs by heat action when, a liquid becomes a gas. The 
human body is formed of approximately 70% of water and a large amount of this is released 
via the skin (by mucous membranes and breathing) [52].  
2.1.2 Anatomy of nerves, arteries and veins of the face 
Since the study in control group involves the face, it is necessary to understand its 
anatomy: nerves, arteries and veins. One of the major nerves of the face is the trigeminal 
nerve. It is a nerve responsible for sensation in the face and some motor functions such as 
biting and chewing.  It is the largest of the cranial nerves. It has three major branches: the 
ophthalmic nerve, the maxillary nerve, and the mandibular nerve. The ophthalmic and 
maxillary nerves are purely sensory, while the mandibular nerve has both cutaneous and 
motor functions. Parallel pathways in the central nervous system process sensory information 
from the face and the body.  
The dermatomes (area of skin that is mainly supplied by a single spinal nerve) of the 
three branches of the trigeminal nerve have sharp borders with relatively little overlap.  
Injury or disease processes, though may affect two or all three branches of the trigeminal 
nerve, and in these cases the involved branches may be termed as illustrated in figure 4, both 
the anterior and lateral view [22]. 
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Figure 4: Dermatome distribution of the trigeminal nerve (v1- ophthalmic nerve, v2-maxillary nerve and v3-
mandibular nerve) [24]. 
On the other hand, a series of veins and arteries provides circulation of blood to the 
various tissues of the face. Most superficial arteries of the face are branches or derivates of 
the external carotid artery. It arises from the external carotid artery and winds its way to the 
inferior border of the mandible. Most external veins are drained by veins that accompany the 
arteries of the face [23]. The superficial arteries and veins of face and scalp are represented 
in figure 5. 
 
 
Figure 5: Superficial arteries and veins of face and scalp [26]. 
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2.1.3 Skin Neoplasms 
Neoplasm originates in the cells, which are the main components of tissue. Usually, these 
grow and divide in order to form new cells. During their life cycle, they age, die and are 
replaced by new cells. However, many times this process does not happen efficiently, leading 
to the formation of a population of extra cells, which frequently forms a mass tissue called 
neoplasm. A neoplasm can be benign or malignant, with the latter being called cancer [24]. 
A benign neoplasm is localized, manifests itself by taking up space, does not invade 
adjacent tissues, does not metastasize and can be easily removed without growing back. It 
rarely puts the patient's life at risk [25, 26]. Among these are seborrheic keratosis, actinic 
keratosis, melanocytic nevus and dysplastic nevus (as can been see on figure 6). Seborrheic 
keratosis is a common skin growth that emerges through the epidermis. It may look 
worrisome, but is benign. Most often keratosis are tan or brown. Actinic keratosis is a rough, 
dry, scaly patch or growth that forms on the skin. It is considered a premalignant condition. 
Melanocytic nevus are small patches on the skin which may be flattened or raised. Usually are 
round and have regular format. The majority of melanocytic nevus appear during the first 
two decades of a person’s life. Dysplastic nevus have different appearance of the 
melanocytic nevus. Usually are larger than the previous, and their edges can be irregular or 
undefined. 
 
Figure 6: Different types of benign skin neoplasms, A- seborrheic keratosis, B- actinic keratosis, C- melanocytic 
nevus, D- dysplastic nevus (adapted from [16)]. 
In contrast, a malignant neoplasm has the ability to invade adjacent tissue, to 
metastasize, and even after being removed, cells may grow back. Also it has the ability to 
spread to other parts of the body, which can become fatal for patient [25, 26]. In other 
words, a malignant neoplasm is characterized by an abnormal cell growth, caused by multiple 
changes in an individual's gene expression, leading to an uncontrolled balance in cell 
proliferation, thus causing cellular death [27]. 
A malignant skin neoplasm is a tumour formed by skin cells which have suffered changes 
and multiplied abnormally, creating new tissue [17, 26]. According to literature, the most 
commonly known malignant skin neoplasm are basal cell carcinoma, squamous cell carcinoma 
and melanoma. On the other hand, the rarest is merkel cell carcinoma. 
A basal cell carcinoma begins in the basal cell layer of the skin. It usually appears in parts 
of the body frequently exposed to the sun. In women, approximately 80% of cases happen in 
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the head and neck, and can appear quite frequently in the face, torso and lower limbs. It is 
slow-growing, but, if it spreads deeply, it can cause major damage, especially around the 
eyes, nose and ears [28]. 
A squamous cell carcinoma is the most common type of malignant skin neoplasm found in 
dark-skinned individuals. It is characterized by the uncontrolled growth of abnormal cells, 
which starts at the squamous cells located in the epidermis. This pathology can occur in all 
areas of the body, including mucous membranes and genitalia. However, the areas where this 
type of tumour appear are those more frequently exposed to the sun, such as the earlobes, 
lower lip, face, scalp, neck, hands and also the legs [29–32].  
Melanomas start in the melanocytes that can occur at the surface of the skin. In men, 
they are frequently found in the head or neck, but they can also be found in other anatomical 
locations such as the shoulders and hips [17]. In the case of women, they are more commonly 
found in the skin of the lower legs, between the shoulders or in the hips. Melanoma is rare in 
darker-skinned people. In this type of population, it appears in areas such as under the finger  
and toenails, in the palms of the hands or in the soles of the feet [17]. 
The three most famous types of malignant skin neoplasm can be seen in figure 7. 
 
Figure 7:Different types of malignant skin neoplasms, A-basal cell carcinoma-, B-squamous cell carcinoma, C-
Melanoma (adapted from [28], [29]). 
Merkel cell carcinoma is a very rare type of skin cancer that affects merkel cells. These 
cells are found in the top layer of the skin and are very close to the nerve endings that 
receive the sensation of touch. Merkel cell carcinoma forms when merkel cells growth out of 
control. Tends to grow quickly and to metastasize (spread) at an early stage. 
Besides what has been previously mentioned, the high skin temperature frequently 
observed in skin neoplasms is caused by an increased blood flow in the affected area. This 
blood flow can happen due to hyper-vascularization (an increase in the size of blood vessels) 
associated with neoplasm malignancy, or a higher blood flow through microvascular 
structuring [26, 33]. 
2.1.3.1 Skin cancer risk factors 
There are multiple risk factors associated with the onset of skin cancer. The risk factors 
described in literature and which are common to these three types of cancer are exposure to 
sunlight, deep sunburns, use of tanning beds, personal clinical history, family history, skin 
that burns easily and some clinical conditions (such as some immunosuppressant drugs, 
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antibiotics, hormones or antidepressants which make the skin more sensitive, and some 
clinical conditions that suppress the immune system) [17].  
The high risk factor associated to the development of skin cancer is exposure to UV 
radiation [34]. When the skin is under intense sunlight, its immune system is weakened, 
which means the genetic material of the cells is damaged and changed, i.e., DNA is directly 
affected [35]. The damage caused by UV radiation cannot be eliminated by the human body 
defence mechanisms. As such, this incorrect information is transmitted to future daughter 
cells, and can later lead to skin cancer [36–38]. 
Similarly, severe sunburns, present themselves as a result of prolonged sun exposure, 
increasing the probability of contracting skin cancer, as that reaction indicates that a large 
quantity of UV radiation has deeply penetrated the skin [39].  
Additionally, tanning beds used in tanning salons contain artificial tanning lamps, which 
offer a quick and effective alternative to natural sunlight. However, there is growing 
evidence that UV radiation emitted by these lamps can damage the skin and significantly 
increase the probability of developing skin cancer [36, 37].  
The person's clinical history is also important, since a patient who has had one of these 
types of neoplasm before has an high risk of developing another type of skin neoplasm [38]. 
Family history must also be considered a risk factor. Melanoma can be hereditary, if anyone 
has two or more close relatives who have contracted melanomas, there is an higher 
probability of later developing this disease. About 10% of all people with melanoma has a 
family history of this condition [5]. 
Other important risk factors include skin that burns easily, people with freckles, low 
phototype, light hair, blue or grey eyes, red or blond hair and also clinic conditions such as 
some antibiotics, hormones, antidepressants (increase skin sensitivity) [5]. 
In the case of basal cell carcinoma and squamous cell carcinoma, there are more specific 
risk factors, such as old scars, burns, ulcers and inflamed skin areas, arsenic exposure and 
radiation therapy [17, 40-42]. 
For the particular case of squamous cell carcinoma, actinic keratosis and Human 
papillomavirus (HPV) are considered to be risk factors [43–45]. Finally, when it comes to 
melanomas, other than what has been previously indicated, one should also consider risk 
factors such as the dysplastic nevi. These are benign nevi, and not common, which can 
resemble melanoma, and people with a large number of this type of nevus spread over their 
bodies are more likely to later develop melanomas [46, 47]. 
2.1.3.2 Diagnosis and treatment 
Much dermatological pathologies can be diagnosed through their clinical appearance, i.e. 
what they look like to the naked eye. The characteristics of an early clinical diagnosis are 
similar, regardless of the medical location. It is essential that doctors are able to recognize 
these characteristics [48]. 
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Unlike benign pigmented lesions, which are usually round, symmetrical and have regular 
borders, malignant lesions are usually asymmetrical and their borders are irregular. Unlike 
pigmented lesions, melanomas can present various shades between brown and black and have 
diameters larger than 6 mm. Thus, this classification can be made for the superficial 
spreading melanoma, based on the ABCD classification system (A-asymmetry, B-border 
irregularity, C-colour variation, D-diameter) [49]. The differences between malignant 
neoplasms and benign neoplasms based on the ABCD classification can be seen in figure 8. 
 
Figure 8:Differences between benign and malignant neoplasms relatively to ABCD analysis [50]. 
In table 2 are described the different diagnosis techniques and treatment options to the 
four types of skin cancer. 
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Table 2:Different diagnosis techniques and treatment options to the various types of skin cancer [5, 17]. 
Types Diagnosis Treatment 
Melanoma 
Medical history and physical exam 
(ABCD and Woods examination) 
Biopsy (punch or excisional or 
incisional) to confirm. 
To determine the extent:  
Sentinel lymph node biopsy  
Imaging tests (CT, MRI and PET) 
Surgery 
Chemotherapy 
Immunotherapy 
Radiation therapy 
Targeted therapies (vemurafenib, trametinib, 
dabrafenib, and ipilimumab) 
   
Basal cell 
carcinoma 
Medical history and physical exam 
Biopsy (punch or excisional or 
incisional) to confirm. 
 
Surgery (excision, Mosh surgery and 
Cryosurgery) 
Curettage and electrodessication 
Topical treatments (imiquimod and 
fluorouracil) 
  Medication – vismodegib (adavance stage) 
Squamous cell 
carcinoma 
Medical history and physical exam 
Biopsy (punch or excisional or 
incisional) to confirm. 
 
Surgery (excision, Mosh surgery and 
Cryosurgery) 
Curettage and electrodessication 
Radiation therapy 
Photodynamic therapy 
Laser therapy 
Chemotherapy creams (5-fluorouracil) 
Merkel cell 
carcinoma 
Medical history and physical exam 
Biopsy (punch or excisional or 
incisional) to confirm. 
To determine the extent:  
Sentinel lymph node biopsy  
Imaging tests (CT, MRI and PET) 
Surgery (excision and Mosh surgery) 
Lymphadenectomy 
Radiation therapy 
Chemotherapy 
 
2.2 Thermology 
Thermal energy transfer can occur through four different mechanisms individually, or 
often simultaneously: conduction, convection, radiation and evaporation. The necessary 
condition for a heat transfer is the existence of a temperature differential or thermal 
imbalance. 
Conduction can be described as a mechanism that transfers thermal energy through a 
contact between two solid masses [51]. 
Convection is a process of thermal energy transfer between a solid surface and an 
adjacent moving substance (liquid or gas). In natural convection, the fluid motion is due to 
density difference, which is caused by temperature difference. In induced convection, the 
fluid motion is caused by external forces (for example a ventilator) [51]. 
Energy transfer by radiation results from the radiant emission (electromagnetic or 
photonic) by a body with a temperature above -273.15 °C (0 Kelvin). Radiation is a 
volumetric phenomenon because it is related to the system volume. All solids, liquids and 
gases emit, absorb, or transmit radiation in various degrees. In solids, however, the radiation 
is normally considered as a superficial phenomenon. This happens because the internally 
emitted radiation never reaches the surface and the incident absorbed radiation reaches only 
a few microns of thickness surface [51]. 
15 
Thermography is a technique that allows mapping a body or region skin surface 
temperature. The use of thermography has various applications such as electrical 
installations, testing of structures and entire buildings, meteorology and medicine [54]. 
2.2.1.1 Physical principles 
The amount of radiated electromagnetic energy of an object is directly related to its 
temperature. An object can be characterized by its capacity of absorbing or emitting 
electromagnetic radiation [55]. 
Infrared radiation occupies in the spectrum the region between the visible and microwave 
radiations. All objects in the universe emit radiation in the infrared region as a temperature 
function. When an object becomes warmer, it emits a more intense infrared radiation and 
radiates with a shorter wavelength. Figure 9 illustrates the electromagnetic spectrum in 
terms of frequency and wavelength. The human eye cannot detect infrared rays [55, 57-59].  
 
Figure 9:Frequency and wavelength of the electromagnetic spectrum [56]. 
Stephan-Boltzmann law states that the total energy radiated by a black body, both per 
unit of surface area and unit of time is directly proportional to the fourth potency of its 
thermodynamic temperature T. Stephan-Boltzmann law can be expressed as: 
   𝑅𝑡 = 𝜎𝑇
4 (1) 
where 𝑅𝑡 represents the total radiance (w/𝑚
2), σ the Stephan-Boltzmann constant 
(5,6697x10−8 𝑊. 𝑚−2. 𝐾−4), and T the absolute temperature emitted by the material (K). 
2.2.1.2 Infrared Cameras 
Although infrared radiation is not perceptible to the human eye, infrared cameras are 
able to convert it into an image that depicts thermal variations across an object surface. 
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Thus, infrared cameras are instruments used in thermography to monitor and record the 
surface temperature of an object [55]. 
Thermal cameras can have lens with different angles, the normal angle is 24º (for closer 
distances) and the wide angle lenses 45º (for longer distances) [62]. 
It is also important to consider other features in respect to these cameras, such as 
temperature range, thermal sensitivity, thermal resolution, spatial resolution, accuracy and 
responsivity. 
The temperature range is the sensor ability to detect heat waves along a certain range of 
temperatures. 
Thermal sensitivity defines the ability to distinguish changes between energy levels. It is 
expressed in terms of temperature. A low value implies high sensitivity. The most commonly 
used methods for thermal sensitivity are the noise equivalent temperature difference (NETD) 
and the minimum detectable temperature (MDT). 
The minimum resolution of an instrument is defined as the smallest difference that the 
instrument is capable to distinguishing. The resolution can be quantified in two ways, 
minimum resolvable temperature difference (MRTD) and slit response function (SRF). 
Spatial resolution is the number of the pixels of image, given by columns and lines. 
Accuracy is the measure of how close the object temperature is to the true value 
(typically ± 2% of the overall reading) [57].  
 
2.2.2 Medical Thermography 
Contact thermometry for many years was the only available method to determine human 
temperature. Thermometry was slowly developed by Galileo experiments in 1592 [63, 64]. 
Sanctorio Sanctorius, an Italian physiologist, who invented a clinical mouth thermometer, 
gave a major step. With this new technology Sanctorius performed quantitative experiments 
with temperature, respiration, weight, and insensitive perspiration, which laid the foundation 
for metabolism investigation. 
Carl Wunderlich, a German physiology and diagnostic methodologist expert became 
known for characterizing several conditions [65, 66].  
In 1800, William Herschel, an amateur astronomer, discovered the existence of infrared 
radiation. In 1840, after the death of William, John Herschel, his son drew a simple picture of 
the evaporation process due to a mixture of carbon and alcohol using focus sunlight, which he 
called "thermogram" [67]. 
JD Hardy, an American physiologist, in 1935, demonstrated that the surface of human skin 
has similar characteristics of a blackbody radiator, being highly efficient at radiating heat 
exchange [68]. 
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Meanwhile, Professor Samuel Langley provided a major contribution by developing the 
bolometer, an instrument used in the measurement of incident electromagnetic radiation. 
This tool forms the basis for a new generation of heat sensors technology. 
In UK, Dr. Max Cade built an infrared thermographer, using an indium antimonide 
electronic detector (InSb). Then, it was created in 1960 the Pyroscan, the first British 
medical thermographer [67]. 
The first study published with the thermography application in medicine, was performed 
by Ray Lawson et al., in 1956, where patients with breast cancer were examined by 
asymmetric hot spots and vascularity in medical thermography images [69]. The role of this 
technology in medicine has increased [33, 71–73]. Such advances include a new generation of 
infrared technology, intelligent image processing algorithms, and better physiological 
understanding of the captured images. Thus, thermography becomes a new way to monitor 
the temperature, non-invasive, non-ionizing, unexpensive, convenient and well accepted by 
the patient. 
Medical thermography is a technique based on skin surface temperature analysis (figure 
10). 
 
Figure 10: Thermography of woman face in two different positions. 
This technique is passive, and relies in the registration of the thermal radiation emitted 
by the skin surface through an appropriate instrument that creates an image of the surface’s 
temperature. The protocol recommended for medical thermography defines that the 
environment temperature should be between 18 and 24 ºC to facilitate the thermal 
equilibrium [9, 74, 75]. 
2.2.2.1 Thermography in Dermatology 
The clinical use of thermography in dermatology was first reported by Brasfield et al. [76] 
in 1964, which indicated the hyper-thermic finding of cutaneous melanoma. 
In the following years, many researchers [76-98] had been concerned to investigate the 
application of medical infrared imaging in the area of dermatology. Thermography research 
has its focus in four main fields: melanoma diagnosis, follow-up of skin cancer, basal cell 
carcinoma diagnosis and temperature differences in skin surface. 
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2.2.2.1.1 Melanoma Diagnosis  
In 1977, Tapernoux B. et al. [77], investigated thermography as a tool for the diagnosis of 
malignant melanoma, and demonstrated a correlation between hyperthermia and malignancy 
in about two-thirds of the cases examined.  
Similarly, Diem et al. [78] evaluated the ability of contact thermography in cutaneous 
melanomas diagnosis. It was suggested that this technique should be used only as 
complementary method. It was concluded that positive thermograms should lead to a 
malignancy diagnosis without being pathyonomic of malignancy.  
In contrast, Cristofolini et al. [79] suggested that thermography is useless for diagnosis 
and follow-up of cutaneous malignant melanomas. They concluded that false-negative and 
false-positive thermograms of metastatic lymph nodes, subcutaneous nodules and removal 
site of cutaneous malignant melanomas were too numerous. 
Hartmann M. et al. [80] studied telethermography as a diagnosis of malignant melanoma 
method. In addition, a complete body thermography is complementary to established 
examination techniques used in evaluation of patients with malignant melanomas. By making 
visible hypo- or hyper-thermic areas, it helps to detect metastases and confirms or denies 
suspicious findings obtained by other examination methods.  
In 1985, Michel U. et al [81] used infrared thermography in a group of clinically suspected 
patients of having primary malignant melanoma, suggesting that the larger malignant 
melanoma was warmer in comparison with the smallest. The highest measurements of 
infrared radiation were obtained in the nodular and acrolentiginous malignant melanoma, 
when compared to other melanoma types. 
Later, studies of Novak OP. et al. [82] proved that the examination thermographic 
method was very effective in complex situations, such as patients with complex skin 
melanomas, early tumour metastasis and recurrence of operative treatment. 
Di Carlo et al. [83] described that the usage of different types of thermography, for 
example, contact thermography or tele-thermography and their clinical applications, with 
emphasis to melanoma. Tele-thermography is based on the capture at a distance of the 
infrared energy emitted by the cutaneous surface, and the conversion of this into a video 
signal. He suggested the application of thermo stimulation assisted tele-thermography to 
solve the problem of false-negative results reported by other authors [79, 84]. By this 
procedure it was possible to evaluate the thermogenic capacity of skin lesions against that of 
the skin in which they are seated, based on the different times of visualization on the screen. 
In the case of malignant cutaneous tumours, when the skin area concerned is cooled, a very 
quick hot spot of the tumour follows, given its high esothermic metabolism, whereas the 
hypothermia of the healthy skin protracts. It was concluded that thermo stimulation assisted 
tele-thermography can be considered a valid and very useful diagnostic tool, not only in the 
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diagnosis of skin tumours (particularly melanomas), but also in more extensive applications 
concerning the microcirculation physiopathology. 
Buzug TM. et al. [85] investigated the early diagnosis of malignant skin cancer by 
functional infrared imaging. It was assumed that malignant melanoma had higher 
metabolism, increasing blood flow and presented slightly higher temperature when compared 
to the healthy skin. It was concluded that this method turns out to be promising, especially in 
the case of basal-cell carcinoma, because it yields a clear diagnostic result. 
Cila Herman et al. [86] explored the feasibility of infrared imaging as a cost-effective and 
non-invasive technique. It was used in optical measurements for tumours detection, 
particularly on the screening and early detection of melanoma. The data presented were 
obtained in patients who had a pigmented lesion previously diagnosed by a biopsy. They 
compared the differences in thermal responses between normal and malignant tissue with 
the results obtained by the biopsy. They used a protocol for image acquisition that involves 
various steps. In short, they applied a stream of cold air to the area of the patient’s skin 
containing the lesion as well as a 50 mm diameter-surrounding region, for the duration of one 
minute. After that, they remove the cooling stress to allow the skin to re-warm at room 
temperature. During the thermal recovery phase, infrared images of pigmented lesion were 
captured every 2 seconds. Finally, all IR images were saved and stored using the LabVIEW 
software. IR images are analyzed using a Matlab code in order to obtain accurate transient 
temperature distributions on the skin surface. The conclusion was that increased metabolic 
activity of melanoma lesion could be detected through dynamic infrared imaging. 
Later, in 2012, Amber L. Shada et al. [87] tried to obtain preliminary estimation of the 
sensitivity of infrared images for the melanoma metastasis detection, and also to detect 
metastases, primary on melanomas and nevi. It was also evaluated the reliability of 
thermography in terms of time logistic constraints and patients tolerability. The conclusion 
was that melanomas with more than 15 mm of diameter are able to be distinguished from 
other lesions with excellent sensitivity and specificity (95% and 100% respectively). On the 
other hand, thermography proved to be tolerant and highly reliable in clinical scenario. 
Finally, they also observed a great potential of this technique in the evaluation of tumour 
response to systemic therapy. 
Recently, in 2014 Mathias Bonmarin et al. [88] evaluated lock-in thermal imaging for the 
early-stage detection of cutaneous melanoma. They used a computational model to derive 
the transient temperature of skin surface subjected to periodic convective heat transfer. The 
technique demonstrates a great ability to reject disrupting thermal signals coming from sub-
cutaneous circulatory and metabolic variations. It was concluded that lock-in thermal imaging 
exhibit a high signal-to-noise ratio and due to its ability on suppress lateral heat spreading, 
allows an accurate detection of lesion margins.  
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2.2.2.1.2 Follow-up of skin cancer 
Bourjat P. et al. [89] investigated various malignant melanoma cases which had not been 
subject of surgical intervention, and proposed a prognostical classification that enables a 
malignancy evaluation. They also investigated thermography in follow-up detection of local 
recurrences and/or lymph-node metastases in an infra-clinical state.  
Later, Michel U. et al. [90] performed the same study, but with patients with malignant 
melanomas. They used the preoperative infrared tele-thermograms that were obtained from 
the draining lymph node, in order to be compared with the clinical and histologic research 
data. They concluded that the majority of cases (around 95%) with metastic spread of 
malignant melanoma had a considerable degree of hyperthermic radiation in the respective 
axillary or inguinal area. 
In 2009, G. A. Santa Cruz et al. [91] investigated the ability of dynamic thermography in 
monitoring melanoma patients who are treated with Boron neutron capture therapy (BNCT). 
It was explored the potential of this technique to evaluate early changes in normal skin, as 
well as the evolution of the tumour after treatment. These authors concluded that 
thermography might be a useful and sensitive tool to study skin toxicity and control of 
melanoma treatments with BNCT. This technique can also help locate abnormal regions with 
high temperature as nodules of melanoma, which are virtually invisible on CT images because 
of their small contrast differences when compared to normal tissue. 
In the same year, Babak Kateb et al. [92], briefly discussed the current status of 
intraoperative imaging modalities including Intraoperative Thermal Imaging (ITI). It was also 
presented a case report that evaluated the usefulness of ITI in brain tumour detection and its 
margins, more specifically in a patient with a metastatic intracortical melanoma. The results 
of this study suggested that thermal imaging could be used to provide a rapid, non-invasive 
and real-time intra-operative technique. They concluded that ITI was a cost-efficient imaging 
method to assist surgeons in identifying tumour location and potentially detect vasculature 
and other acute abnormalities during the surgery. 
Mikulska et al. [93] performed a comparative study with dermoscopy, thermography and 
histopathology of cutaneous melanocytic nevi. They concluded that thermography may 
supplement dermoscopy during examination of atypical melanocytic nevi and other skin 
lesions suspected of neoplastic metaplasia. Additionally, average temperatures of benign and 
atypical melanocytic nevi do not differ significantly from the average temperature of the skin 
without pigmented lesions. 
A transient thermal imaging system was developed in 2011 by M. Pirtini Çetingul. [1], that 
allows a more accurate measurement of temperature differences in skin surface. The aim was 
to aid the detection and diagnosis of metabolically active or malignant skin lesions. It was 
observed that the feasibility of this technique to distinguish benign from malignant 
pigmented lesions, and thus, quantify the malignant potential of lesions. The data obtained 
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from benign and malignant images was compared, and more specifically, correlated the 
thermal recovery images and data with biopsy results to define thermal associations with 
malignant potential. Geometrical data obtained from the digital and dermoscopy images was 
also used and a biopsy report in its computational model to simulate the thermal response of 
the analyzed lesion. At the end, the results from the modelling effort were compared with 
clinical data. The thermal response of benign lesions was found to be similar to that of 
healthy skin tissue. This difference can be used to identify malignant lesions and quantify 
their malignant potential. On the other hand, the computed results showed that the lesion 
parameters and properties can be estimated and the influence of malignant lesion on the 
transient thermal response can be quantified with their computational model. 
2.2.2.1.3 Basal Cell Carcinoma Diagnosis 
In 1981, several studies were performed. Ratz JL et al. [94] described Liquid-crystal 
thermography as it is applied to basal-cell carcinomas. Results indicated that it is useful for 
moderate to heavy cellular density neoplasms but little help in outlining neoplasms of low 
cellular density like morpheaform basal-cell carcinomas. 
In 2011, J.H.Flores Sahagun et al. [95] performed an evaluation of infrared imaging 
viability in the basal cell carcinoma diagnosis using a normalized conjugated gradients 
methodology. It was proposed a methodology that has been tested by temperature 
measurements using infrared imaging and a healthy control group to establish expected 
normality ranges of basal cell carcinoma patients. The proposed method allows the 
comparison of measured dimensionless temperature difference values between two 
symmetric regions of patient’s body, taking into account the skin, the surrounding ambient 
and the individual core temperatures. It was concluded that the normalized conjugated 
gradients method was simple and capable to differentiate normal from injured tissue and also 
the conjugated gradients method was efficient to identify injured tissue. It also concluded 
that the use of dimensionless temperature compensates the temperature readings with 
respect to variations in the individual’s metabolism and ambient temperature at the 
particular location of the exam. 
2.2.2.1.4 Temperature differences in skin surface 
Amalric et al. [96] investigated the ability of dynamic tele-thermography in the direct 
observation of infrared rays emission from the skin of the human body. A number of 
dermatological diseases such as malignant melanomas can modify this emission and show a 
larger variation in skin temperature. They defended that other skin black tumours may also 
benefit from this method. 
M. Pirtini Çetingul jointly with other researchers had published several interesting studies 
[1, 97, 98] with the aim of helping the detection of early malignant lesions in the skin. In 
2008, a study [31] based in the use of transient thermal response of skin layers, allowed the 
determination of the temperature distribution that reflect the properties of subsurface 
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structures such as lesions. The evaluation of this study was performed by sensitivity metric of 
the following variables: the surface temperature distribution, variations of thermo-physical 
properties, blood perfusion rate and thickness of skin layer. First, the model was used to 
investigate the importance of the aforementioned parameters for surface temperature 
distribution. Next, the time evolution of the infrared signal was analyzed after a cold stress 
that was applied to human skin. By considering both, the steady state and transient results, 
information about the size and depth of masses within the skin layers was registered during 
recovery. It was observed that variations in these parameters had minimal effects on surface 
temperature distribution. By selecting the duration of cooling stress, the internal 
temperature of the skin changes, and this change can be felt at different depths. One year 
later, the same investigators [98] developed a thermographic system that allows accurate 
measurement of small temperature differences on the skin surface. This study’s purpose was 
mainly diagnose malignant and pigmentation skin lesions in an early stage of the disease. The 
method developed by these authors was based on active thermography and a multimodal 
image analysis strategy, including correction of involuntary body movements and 
segmentation of pigmented lesions in order to detect malignancy. The system described in 
this study was tested in a group of patients who had pigmented lesions and also clinical 
indication for biopsy. The lesions and surrounding tissue received a source of cool air for a 
period of time (between 30 and 60 seconds). The thermal recovery was recorded by an 
infrared camera, generating an image of the lesion after the application of the cold source. It 
was concluded that the benign lesions had a similar thermal recovery to normal skin, while 
melanomas presented a higher temperature than healthy skin during the process of thermal 
recovery. 
2.2.2.2 Thermal symmetry 
A region of interest (ROI) is a selected subset of samples within a dataset identified for a 
particular purpose. Thermal symmetry is defined as the degree of similarity between two 
ROIs, mirrored across the human body’s longitudinal main axes which are identical in shape, 
identical in size, and as near identical in position as possible. Based on the fact that the 
human body is bilateral and practically fully symmetrical with respect to its extremities, the 
indication is that the human body can have bilateral temperatures symmetry between two 
ROIs in co-lateral locations.  
Significant differences in bilateral temperatures symmetry can be related to pathological 
states such as structural abnormalities of blood vessels, abnormalities of vascular control, 
local effects on blood vessels, changes in thermal conductivity of the tissues and increased 
heat production in the tissues.  
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Table 3:Thermal symmetry of some ROIs using Medical Thermography [99, 100]. 
Region of interest Mean and SD values 
Face 0.30 ± 0.20 
Neck 0.40 ± 0.30 
Arm, upper 0.50 ± 0.40 
Forearm, dorsal 0.50 ± 0.30 
Forearm, volar 0.30 ± 0.20 
Trunk, upper 0.30 ± 0.20 
Trunk,medium 0.40 ± 0.30 
Trunk, lower 0.30 ± 0.20 
Back, upper 0.20 ± 0.20 
Back, medium 0.30 ± 0.20 
Back, lower 0.30 ± 0.30 
Leg, anterior 0.30 ± 0.30 
Leg, posterior 0.20 ± 0.20 
Thigh anterior 0.20 ± 0.20 
Thigh posterior 0.20 ± 0.10 
The values taken in consideration are the mean temperature of the ROI and its standard 
deviation. Table 3 shows these values from the regions of the body that were studied [99, 
100]. 
2.2.3 Non-invasive competing techniques  
In this subsection some alternatives to medical thermography are presented as well as 
their advantages and disadvantages and subsequent comparison with infrared thermography.  
2.2.3.1 Contact Thermography 
According Sherman et al. [101], the majority of contact thermography systems consists in 
series of detectors and flexible pillows, generally about 18 (within 46 cm) on each side, 
containing crystals vectors that changes colour corresponding to a specific temperature. The 
crystals that are sensitive to different temperatures are closely spaced to form similar pixels 
to those that produce colloidal images on a TV screen.  
In this technique, the pillow is pressed against the body part to be analyzed, and then a 
colour image is produced with multiple pixels. Temperature differences are required to 
produce various colours. The differences between each colour may vary from 0.3 to 1.1 °C. 
This device is theoretically accurate to 0.2 °C [101]. 
The main advantages of this technique is cost effectiveness, easy to use and calibrate, is 
suitable for curved surfaces, have a high spatial resolution and it can be reusable [55]. 
However, the readings are ordinal, but not continuous, because the data are limited to 
parametric statistical methods and comparisons between devices are limited to non-
parametric methods. Contact thermography cannot be used to long term records because the 
pressure exerted by the plastic screen in the body, changes the heat surface patterns. Also 
has difficulty reading temperatures on low lighting conditions, has a limited range of 
temperature and it is a slow technique, because there is the need for a slow photographic 
record [55, 101]. 
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2.2.3.2 Laser Doppler Flowmetry 
According Frerichs et al. [102], Laser Doppler Flowmetry technique allows a non-invasive 
and continuous measuring of the local microcirculation and blood flow. The flow estimate is 
based on the evaluation of the Doppler shift with low-energy laser light, which is scattered by 
the moving red blood cells [103]. 
2.2.3.3 Laser Doppler Perfusion Imaging (LDPI) 
According Serov et al. [104], LDPI is an interferometric technique successfully used on 
two-dimensional visualization of microvascular flow maps and a large number of clinical 
investigation, including cardiovascular disease, skin irritations, diabetic condition, organ 
transplantation and burns. Two-dimensional flow maps are obtained by successive 
measurements of predetermined points. 
Fujii et al. [105] and Briers et al. [106] proposed an alternative method, full-field flow 
imaging techniques, which use a contrast analysis using stains/splashes to monitor blood 
flow. 
 
2.3 Summary considerations 
The traditional method used to diagnose the skin cancer is biopsy. However, medical 
thermography has shown great potential in the clinical diagnosis of various situations, 
including some skin cancers. Medical thermography allows mapping a body or region of skin 
surface temperature. This technique enables the detection of inflammation, as well as 
changes in functional activities, even when there are no changes at the physical level. The 
other complementary diagnostic methods do not reveal these information. 
 
  
  
Chapter 3.  
Materials and Methods 
The methodology used in this study lies in the characterization of the temperature 
distribution in patients with skin neoplasms, and follow-up of skin neoplasms and 
asymptomatic individuals. This is a retrospective and observational study, it is based on a 
quantitative methodology, analyzing the data systematically and establishing relationships 
between variables, in order to characterize the problem. In this chapter the necessary 
equipment for image acquisition is described, as well as the sample characterization, the 
data collection and analysis protocol. 
 
3.1 Equipment 
The equipment used for data collection includes the infrared camera FLIR A325, the data 
logger Testo 175 H, a tripod and a VTR-16P fan (220-240 V, 50 Hz, 60 W). The FLIR A325 
infrared camera is designed from the ground-up to deliver accurate thermographic imaging 
and repeatable temperature measure necessary in this study. In all collections the camera 
was placed at approximately 80 cm from the individual, with a 90º angle and over a tripod at 
120 cm height. The main features of this infrared camera includes a 320x240 pixels of 
resolution a <50 mk of sensitivity and a accuracy of ±2% of the overall reading.  
The Testo 175 H is a professional data logger used for monitoring temperature and 
relative humidity in enclosed places. Figure 11 illustrates the equipment used in the present 
study for capturing thermographic images in controlled environment.  
Regarding software, it was used FLIR RESEARCHER PRO 2.10 which provides tools for data 
display and analysis. For selecting regions of interest and to extract data, FLIR tools software 
was used. To gather, organize and storage the measurement data was used the Microsoft 
Excel 2013. Finally, for statistical analysis Statistical Package for the Social Sciences 22 (SPSS 
Statistical 22) was used [62, 107]. 
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Figure 11: Equipment for capturing thermographic images, A- Computer, B- Thermographic Camera, C-Tripod, D- 
data logger Testo 175 H. 
 
3.2 Sample Characterization 
The present study is characterized as prospective because it examines two groups; one of 
healthy people (control group) and one with skin neoplasms (oncologic group). The skin 
neoplasm group is divided into recently diagnosed individuals and follow-up individuals 
(people who underwent surgery within a period of two weeks to eight years before). The 
group proportions are presented in the figure 12. 
 
Figure 12: Composition of the population proportions of each group. 
Data collections of asymptomatic individuals were performed at the Faculty of 
Engineering of University of Porto (FEUP) and patients with skin neoplasms in the Portuguese 
Oncology Institute of Porto (IPO-Porto), more specifically in the Plastic and Reconstructive 
Surgery Service. The general conditions of room relative humidity and temperature for both 
groups are show in figure 13 and 14. Box plots were used to locate and analyze the variation 
of relative humidity and temperature variables. For the control group, relative humidity 
showed little variations, having a mean value of 44.30% and a variance of 20.46. The 
temperature also was maintained always within a small acceptable range (<24ºC). However, 
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there were two outliers (stars and circles) outside the upper quartiles, indicating discrepant 
values.  
For the oncologic group, room humidity had more variations, having a mean value of 
55.58% and a standard deviation of 0.75. The temperature had small variations, having a 
median of 24.10 ºC and a standard deviation of 0.57. These temperature values are higher 
than desired. However, there was also an outlier (circle) below the lower quartile. 
 
Figure 13: Room humidity distribution in both groups. 
At FEUP, 42 volunteers were collected, 23 female and 17 male, where 2 were excluded 
because they did not meet the inclusion criteria. Data collections at FEUP occurred during 
the month of May 2014. 
  
Figure 14: Room temperature distribution in both groups. 
At IPO-Porto, 108 lesions in total were collected. Five lesions were excluded because they 
didn't meet the inclusion criteria. Of the remaining 103, 58 belonged to diagnosed group (26 
female and 32 male) and 45 to follow-up group (24 female and 21 male). On the diagnosed 
group, 75.9% were malign and 12.5% of the follow-up group were benign. Data collections in 
IPO-Porto occur one day a week since June until August of 2014. 
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The general specifications of each group, mean and standard deviation are presented in 
Table 4. Regarding the diagnosed and follow-up groups, the number of different types of 
neoplasms were analyzed. Particularly, benign neoplasms (melanocytic nevus, atypical nevus, 
seborrheic keratosis, acticnic keratosis) and malignant neoplasms (basal cell carcinoma, 
squamous cell carcinoma, melanoma and merkel cell carcinoma). 
Table 4: General specifications of each group in terms of mean and standard deviation. 
 
Characteristics Diagnosed Follow-up Control 
S
u
b
je
c
t 
Age 70.0 ± 336.99 69.0 ± 323.65 23.0 ± 4.46 
Weight 70.46 ± 13.69 72.60 ± 13.5 65.90 ± 10.34 
Height 1.64 ± 0.12 1.62 ± 0.009 1.70 ± 0.07 
BMI 25.96 ± 3.44 27.12 ± 4.61 22.44± 6.00 
Sun Sensibility 31.0 ± 32.47 32 ± 23.29 29.83 ± 4.59 
N 58 45 40 
The type of skin neoplasm more prevalent in the diagnosed group was basal cell 
carcinoma, with 28 cases followed by 11 cases of melanomas and 8 cases of melanocytic 
nevus. Within the less prevalent were seborrheic and acticnic keratosis with 3 cases (figure 
15-b). In follow-up group melanoma stands up with the heights of prevalence, 21 cases, 
followed by basal cell carcinoma and squamous cell carcinoma with 12 and 8 cases 
respectively (figure 15-a). Regarding the follow-up group, the merkel cell carcinoma and 
atypical nevus were only 1 case. As can be seen in figure 15, in both groups there were not 
reported the same types of skin neoplasms. In the skin neoplasm group atypical nevus and 
merkel cell carcinoma are inexistent and in the follow-up group weren’t found seborrheic and 
acticnic keratosis cases. 
Globally, the results were similar, basal cell carcinoma and Melanoma had an incidence of 
40 and 32 cases and Merkel cell carcinoma and atypical nevus had only 1 case. 
Similarly to skin neoplasm the body localization prevalence of them were analyzed. In the 
diagnosed group 40 cases were found in individual’s face (15 cases on the left side, 12 cases 
on the right side, 10 cases in the nose and 3 cases in the scalp) and only 1 and 2 cases in the 
chest and upper limbs (figure 16-b). Contrarily, in the follow-up group the highest incidence 
were in the individuals back with 10 cases and 8 cases in the upper limbs, as can be seen in 
figure 16-a. 
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a)  
 
b)  
Figure 15: Type of neoplasm prevalence in both groups (a- Follow-up group and b- Diagnosed group). 
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a)  
b)  
Figure 16: Skin neoplasm location prevalence in both groups (a- Follow-up group and b- Diagnosed group). 
 
3.3 Data collection protocol 
The data collection protocol represents an important role in any biomedical investigation. 
The protocol adopted for this research follows the guidelines of "Glamorgan Protocol". This 
protocol recommends the standard knowledge for recording and evaluation of human body 
with thermal images [55]. 
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The protocol is based on the objective target of the anatomical region of interest, face 
for the control group and the neoplasm location for the oncological group. To achieve this 
goal, the anatomical landmarks are aligned in each view to the image edge. It allows also to 
reproduce body positions views to increase the thermal image reproducibility [55]. 
The protocol incorporates aspects such as communication, preparation and consideration 
of the patient, exam guidelines, results evaluation and presentation [108, 109].  
The capture protocol recommended for medical thermography defines that the 
environment where the test is performed should have an ambient temperature between 18ºC 
and 24ºC, relative humidity below 50%, air flow less than 2m/s and the absence of incident 
light on the subject. 
Before data collection, ethical approval was requested and obtained from the ethics 
committee of the IPO (appendix I).  
The process of data collection involved several common steps to the three groups under 
test. Before capture, it was necessary that the individual remained in a heated room, 
exposing the area where the lesion was located. This process took about 10-15 minutes, in 
order to obtain the desired temperature. Meanwhile, the individual became aware and filled 
out some questionnaires. Among these were include informed consent, biometric data 
questionnaire, and pathology questionnaire (appendix II, III and IV). The biometric data 
questionnaire include questions about mobility, autonomy, usual activities, discomfort, pain, 
anxiety and depression. The final score obtained in this questionnaire should be zero, for 
inclusion the individual in the study. Only the control group filled this questionnaire. The 
pathology questionnaire includes information on parameters such as sun sensibility, and 
family history. The sun sensibility was scaled between 0 and 40 points (inversely proportional 
to the sun sensibility). For the control group, the phase of menstrual cycle (follicular and 
luteal) was also recorded. 
 It was also essential that the individual knew his weight and height to allow body mass 
index (BMI) calculation. It is defined as the individual’s body mass divided by the square of 
their height, given in units of kg/m2. 
Before the data collection period, some precautions should be taken such as: 
 Not having a heavy foods prior to data collection; 
 No participating in heavy activity or consuming alcohol or hot drinks or smoking 2 
hours prior to the pictures being taken; 
 Wearing minimal clothing in order to obtain clear thermograms; 
 Removing all jewellery prior to the pictures being taken; 
 Refraining from applying cosmetics and ointments to the skin prior to the pictures 
being taken. 
Different capture procedures were adopted for the three groups. For the control group, 
nine different images of face per person were taken, in three different moments and 
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positions. The positions of the face for each set of three images were frontal, right, and left 
profiles. Figure 18 shows some thermograms of the control group in three different moments 
of frontal and right profile. 
 The first three pictures were taken after the acclimatization period and before applying 
a provocation test (first moment). The provocation test was a thermal stimulus consisted in a 
stream of cold air from a fan, facing 90º angle, and applied to the face during 2 minutes. It 
was applied cold air instead of hot, because in humans the colder sensors react faster than 
the warm sensors, and thus the examination can be done in less time. Immediately after the 
application of the thermal stimulus, 3 more images (second moment) were captured. The last 
3 images were captured after waiting 5 minutes, in order to re-establish the normal 
temperature (third moment). 
Thus, it is possible to maximize the physiological response of the face. Figure 17 
illustrates the data collection protocol in three different moments. 
 
Figure 17: Cold stimulation and recovery collection protocol for three different moments. 
For the oncologic group, there was a time constraint to perform the examination, only 
one image was taken by the individual in the neoplasm location, and the thermal stimulus 
could not be applied.  
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Figure 18: Thermograms of control group in three different moments of frontal and right profile (A- 1st moment, 
frontal view; B-2nd moment, frontal view; C-3rd moment, frontal view; D- 1st moment, right profile view; E- 2nd 
moment, right profile view;F-3rd moment, right profile view).  
The neoplasm location included parts of body such as scalp, right face profile, left face 
profile, nose, back, chest, upper limbs (hand, arm, shoulder and axilla) and lower limbs 
(thigh, leg and foot). 
3.4 Inclusion and exclusion criteria 
Table 5 presents the inclusion and exclusion criteria of this study. 
Table 5: Description of the inclusion and exclusion criteria of this study. 
 Inclusion criteria Exclusion criteria 
C
o
n
tr
o
l 
G
ro
u
p
 
- Asymptomatic individuals; 
- Score null in the biometric survey date; 
- Individuals belonging to University of 
Porto. 
- Accented facial hair;  
- Individuals who have consumed caffeine;  
- Individuals who are smokers;  
- Individuals who have makeup or facial cream; 
- Individuals who have practiced intense physical 
exercises on the previous day;  
- Individuals minors (under 18 years). 
O
n
c
o
lo
g
ic
 G
ro
u
p
 
- Have or had skin neoplasms; 
- Be a patient on Portuguese Institute of 
Oncology (IPO). 
 
 
- Accented facial hair;  
- Individuals who have consumed caffeine;  
- Individuals who are smokers;  
- Individuals who have makeup or facial cream; 
- Individuals who have practiced intense physical 
exercises on the previous day;  
- Individuals without neoplasms; 
-Individuals with suspicious neoplasm diagnosis. 
 
3.5 Analysis protocol 
Data analysis was performed using the FLIR tools software which allowed the extraction 
of maximum, minimum and mean temperature values for each region of interest. However, 
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regions of interest were selected in different ways for the two groups. After obtaining the 
results, they were treated in SPSS Statistical 22 using different statistical methods. All these 
aspects are described in the following subsection. 
3.5.1 Control group analysis 
The regions of interest (ROIs) of autonomous nervous system (ANS) were selected 
according to Netter 3-way division [110] both frontal, right and left profile positions. The 
frontal images were divided into 16 regions (8 on the right side and 8 on the left side) using 
squares. The profile images were divided into 8 regions also using squares (see figure 19-A). 
For the same individual, the squares areas were the same for the right and left sides. Then 
this were combined in ROI 1, ROI 2 and ROI 3 according to Netter classification (see figure 20-
A). 
 
 
 
Figure 19: Frontal and profile images with the selected ROIs (A-ANS, B-MS). 
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From the data obtained, it was used the mean value of temperature, both to the left and 
right side in different positions. Thus, the thermal symmetry of ROI 1, ROI 2 and ROI 3 was 
calculated by the equation 3. 
 𝑇ℎ𝑒𝑟𝑚𝑎𝑙 𝑆𝑦𝑚𝑚𝑒𝑡𝑟𝑦 =  |𝑅𝑂𝐼𝑙𝑒𝑓𝑡 − 𝑅𝑂𝐼𝑟𝑖𝑔ℎ𝑡| (3) 
The regions of interest (ROIs) of microvascular system (MS) were selected according to 
Gratt et al. [111] both front, right and left profile positions. The front images were divided 
into 18 regions (9 on the right side and 9 on the left side), while the profile images were 
divided into 10 regions also using squares.  
Such as the ANS, the squares areas were the same for the right and left sides (figure 19-
B). The regions were then combined in ROI 1, ROI 2, ROI 3, ROI 4, ROI 5, ROI 5, ROI 7, ROI 8 
and ROI 9 from front images, and in ROI 1, ROI 2, ROI 3, ROI 4, ROI 5, ROI 6, ROI 7, ROI 8, ROI 
9 and ROI 10 from profile images. So, it was obtained a classification according to Gratt et al. 
(figure 20-B).  
 
Figure 20: Regions of interest of ANS according to Netter (A) and MS according to Grantt (B) [111]. 
3.5.2 Diagnosed and Follow-up group analysis 
The ROIs of oncologic group analysis were selected according the location of neoplasm. 
For all cases, it was used two squares in the neoplasm region (one square in the left of 
neoplasm, other in the right of neoplasm) as can be seen in figure 21 [112]. 
 
Figure 21: ROI selection on skin neoplasm group, A-Basal Cell carcinoma; B-Squamous Cell carcinoma. 
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The squares had an area of approximately 8x8 pixels. In these groups it was calculated 
the absolute difference between the left and right side of skin neoplasms (ΔT). 
 
3.5.3 Case-study 
It was also compared some of the individuals who possessed skin neoplasms on the face 
with a group of controls that had a BMI within the same class and the same gender. In the 
control group, roughly the same square area was selected around the neoplasm (see figure 
22). Thus, it was possible to compare the mean temperature of the individual with skin 
neoplasm with the appropriate control group.  
 
Figure 22: ROI selection in control individual (A) and basal cell carcinoma individual (B). 
A total of 4 cases were tested of diagnosed basal cell carcinoma. The minimum number of 
comparable controls was 14 and the maximum 18.  
 
3.6 Statistical treatment 
Unlike the parametric tests, the nonparametric tests do not require strong requirements 
as normality. They are used when dealing with small samples with a distribution that is not 
normal. They can also be used if, despite the sample having a size greater than 30, when 
more conservative conclusions are sought. Non-parametric tests were considered using a 
significance level of 0.05, table 6. 
The U-Mann Whitney test allows the detection of significant differences between the 
central values of two situations, when considered different subjects. It is the nonparametric 
alternative to the student t-test for independent samples, when the conditions for the 
application of a parametric test are not meet.  
The Wilcoxon test enables the detection of significant differences between the central 
values of two situations, when the same subjects are considered. It represent a 
nonparametric alternative to student’s t-test for paired samples. 
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The Kruskal-Wallis test allows the detection of significant differences between the 
central values of three or more situations, when different subjects are considered. It 
represent an nonparametric alternative to ANOVA for independent samples [113]. 
Table 6: Description of mean distribution equality tests. 
  
Parametric tests Non-parametric tests 
Two paired samples T-student Test* Wilcoxon or Signal Test 
Two independent samples T-student Test* ** U Mann-Whitney Test 
More than two independent samples One Way ANOVA * ** Kruskal-Wallis Test 
The chi-square test for independence verifies if there is a statistically significant 
evidence of association between two characteristics. In other words, it verifies the 
independence between two variables of any type that are grouped together in contingency 
tables. This test should not be used if more than 20% of expected frequencies under the 
assumption of independence are less than 5, or one of them is zero. If this assumption does 
not occur, the Fisher’s test will be used. 
  
  
  
Chapter 4.  
Results 
In this chapter the reader will find the major results of this study. Firstly, the skin surface 
temperature characterization and the influence of individual characteristics on skin 
temperature for autonomous nervous system (ANS) and microvascular system (MS) in the 
control group are described. The skin neoplasm group shows the temperature 
characterization of skin neoplasms and the impact of the individual characteristics. Later, a 
comparison of case-study of basal cell carcinoma in four different face locations with control, 
in order to assess temperature differences was performed. 
 
4.1 Skin surface temperature characterization 
4.1.1 Control Group 
The first study had the purpose of characterizing the temperature at the skin surface in 
the ANS and MS. The ROIs mean temperatures of each side were analyzed in each moment, as 
well as its thermal symmetry. 
4.1.1.1 ANS 
The ANS was characterized in 3 ROIs in both frontal and profile positions. In the following 
tables were presented the mean temperature and the corresponding standard deviations to 
the right and left sides of the ROIs, as well its thermal symmetry. 
Table 7: Mean temperature characterization of the right side in each moment, and the corresponding p-values of 
Wilcoxon test. 
 
ROIs 1st Moment 2nd Moment 3rd Moment pI-II pII-III pI-III 
F
ro
n
ta
l R1 34.35 ± 1.62 32.8 ± 0.52 34.33 ± 0.64 0.000 0.000 0.000 
R2 34.19± 0.42 32.69 ± 0.60 33.94 ± 0.78 0.243 0.000 0.000 
R3 33.64± 0.82 32.15 ± 1.19 33.15 ± 1.84 0.000 0.000 0.000 
P
ro
fi
le
 R1 34.15± 0.56 32.57 ± 0.65 33.91 ± 0.61 0.000 0.000 0.000 
R2 33.78± 0.81 32.38 ± 0.86 33.32 ± 0.92 0.000 0.000 0.000 
R3 33.87± 0.80 32.24 ± 0.87 33.36 ± 0.90 0.000 0.000 0.000 
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It was necessary to assess if the stimulus triggered differences in the mean temperatures 
of each ROI. Through observation it can be concluded that there was a difference of 
approximately 2 ºC in each moment relatively to each ROI (figure 23). 
 
Figure 23: Temperature differences between moments regarding ANS of ROI's. 
By this analysis, it looks like the standard deviation besides being higher, are similar 
between the second and third moment, when compared to the first moment. 
Using the Wilcoxon test, it can be stated that there was significant statistical evidence 
that all mean temperature in each side (right and left) of each ROIs were different between 
moments, with the exception of frontal ROI R2 between moment I and II (table 7 and table 
8).  
Table 8: Mean temperature characterization of ROIs left side in each moment. Are also showed the corresponding p-
values of Wilcoxon test. 
 
ROIs 1st Moment 2nd Moment 3rd Moment pI-II pII-III pI-III 
F
ro
n
ta
l R1 34.70 ± 0.24 32.75 ± 0.46 34.30 ± 0.61 0.000 0.000 0.000 
R2 34.00 ± 0.47 32.49 ± 0.75 33.91 ± 0.72 0.149 0.000 0.000 
R3 33.55 ± 0.78 32.12 ± 0.64 33.42 ± 0.69 0.100 0.000 0.000 
P
ro
fi
le
 R1 34.25 ± 0.29 32.6 ± 0.435 33.90 ± 0.39 0.000 0.000 0.000 
R2 33.77 ± 0.84 32.43 ± 0.90 33.32 ± 0.94 0.000 0.000 0.000 
R3 33.89 ± 0.76 32.53 ± 0.69 33.46 ± 0.73 0.000 0.000 0.000 
Using the Wilcoxon test it can be stated that there was significant statistical evidence 
that all thermal symmetry values of each ROI were equal between moments with the 
exception of frontal ROI R1 between moments I and II and moments I and III (table 9).  
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Table 9: ROIs thermal symmetry in each moment and the corresponding p-values of Wilcoxon test. 
 ROIs 1st Moment 2nd Moment 3rd Moment pI-II pII-III pI-III 
F
ro
n
ta
l R1 0.16 ± 0.14 0.25 ± 0.19 1.05 ± 5.38 0.009 0.286 0.011 
R2 0.19 ± 0.05 0.22 ± 0.14 0.21 ± 0.03 0.562 0.878 0.834 
R3 0.25 ± 0.21 0.30 ± 0.25 0.27 ± 0.21 0.400 0.755 0.459 
P
ro
fi
le
 R1 0.26 ± 0.23 0.32 ± 0.30 0.28 ± 0.24 0.350 0.639 0.512 
R2 0.23 ± 0.16 0.26 ± 0.22 0.20 ± 0.03 0.883 0.431 0.971 
R3 0.18 ± 0.16 0.23 ± 0.20 0.21 ± 0.15 0.174 0.780 0.224 
4.1.1.2 MS 
The MS was characterized in 9 ROIs in the frontal position and 10 ROIs in the profile 
position. In the following tables are presented the mean temperatures and the corresponding 
standard-deviations to the right and left sides of the ROIs, as well its thermal symmetry. 
As ANS temperature characterization in MS it was also necessary to assess if the stimulus 
triggered differences on the mean temperatures in each ROI.  
Table 10 : Mean temperature characterization of ROIs right side in each moment and the corresponding p-values of 
Wilcoxon test. 
 ROIs 1st Moment 2nd Moment 3rd Moment pI-II pII-III pI-III 
F
ro
n
ta
l 
R1 32.20 ± 1.41 30.80 ± 1.48 33.00 ± 3.32 0.000 0.000 0.029 
R2 34.20 ± 0.70 32.75 ± 0.77 34.30 ± 0.90 0.000 0.000 0.656 
R3 33.98 ± 0.79 32.35 ± 0.82 33.79 ± 0.88 0.000 0.000 0.031 
R4 34.61 ± 0.49 32.72 ± 0.72 34.50 ± 0.45 0.000 0.000 0.000 
R5 34.25 ± 0.21 32.99 ± 0.51 33.96 ± 0.47 0.000 0.000 0.000 
R6 33.44 ± 0.95 31.51 ± 1.04 32.99 ± 1.17 0.000 0.000 0.005 
R7 33.75 ± 0.90 32.40 ± 1.12 33.42 ± 1.07 0.000 0.000 0.003 
R8 34.80 ± 0.19 33.40 ± 0.48 34.55 ± 0.34 0.000 0.000 0.002 
R9 33.30 ± 0.49 31.85 ± 0.62 32.75 ± 0.83 0.000 0.000 0.000 
P
ro
fi
le
 
R1 31.23 ± 2.09 30.35 ± 2.13 32.55 ± 6.60 0.000 0.000 0.019 
R2 33.60 ± 1.16 32.37 ± 1.03 33.58 ± 1.01 0.000 0.000 0.027 
R3 33.81 ± 0.68 32.13 ± 0.89 33.66 ± 0.81 0.000 0.000 0.049 
R4 34.45 ± 0.37 32.77 ± 0.71 34.20 ± 0.43 0.000 0.000 0.000 
R5 33.95 ± 0.53 32.87 ± 0.58 33.79 ± 0.53 0.000 0.000 0.006 
R6 33.15 ± 1.21 31.70 ± 1.43 32.68 ± 1.24 0.000 0.000 0.000 
R7 34.00 ± 0.81 32.55 ± 1.18 33.50 ± 1.19 0.000 0.000 0.000 
R8 33.70 ± 0.86 32.18 ± 0.91 33.18 ± 0.91 0.000 0.000 0.000 
R9 34.45 ± 0.72 33.00 ± 0.91 33.93 ± 0.73 0.000 0.000 0.000 
R10 33.56 ± 0.98 31.92 ± 1.00 33.02 ± 1.07 0.000 0.000 0.000 
Using the Wilcoxon test it can be stated that there is significant statistical evidence that 
all mean temperatures in right and left sides of each zone were different between moments 
with the exception of frontal ROI R2 between moment I and III (table 10 and table 11). 
Through observation of figure 24, it can be concluded that there was a difference of 1.5ºC 
in each moment relatively to each ROI. 
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Figure 24: Temperature differences between moments regarding MS of three ROI's. 
By this analysis it is also apparent that the standard deviations besides being higher, they 
are similar between the second and third moment, when compared to the first moment. 
Table 11: Mean temperature characterization of the left side in each moment and the corresponding p-values of 
Wilcoxon test. 
 ROIs 1st Moment 2nd Moment 3rd Moment pI-II pII-III pI-III 
F
ro
n
ta
l 
R1 32.31 ± 1.45 31.02 ± 1.53 33.05 ± 3.31 0.000 0.000 0.029 
R2 33.92 ± 0.68 32.59 ± 0.75 33.92 ± 0.75 0.000 0.000 0.656 
R3 33.92 ± 0.76 32.22 ± 0.80 33.64 ± 0.87 0.000 0.000 0.031 
R4 34.61 ± 0.48 32.73 ± 0.67 34.30 ± 0.47 0.000 0.000 0.000 
R5 34.21 ± 0.47 32.97 ± 0.54 33.95 ± 0.47 0.000 0.000 0.000 
R6 33.42 ± 0.97 31.75 ± 1.04 33.40 ± 1.26 0.000 0.000 0.005 
R7 33.87 ± 0.79 32.22 ± 0.80 33.42 ± 0.92 0.000 0.000 0.003 
R8 34.65 ± 0.34 33.20 ± 0.42 34.30 ± 0.32 0.000 0.000 0.002 
R9 33.45 ± 0.58 31.71 ± 0.98 32.72 ± 0.88 0.000 0.000 0.000 
P
ro
fi
le
 
R1 31.24 ± 2.13 30.95 ± 4.85 33.25 ± 7.96 0.000 0.000 0.046 
R2 33.22 ± 0.99 32.34 ± 1.01 33.80 ± 0.94 0.000 0.000 0.008 
R3 33.74 ± 0.68 32.22 ± 0.89 33.54 ± 0.85 0.000 0.000 0.046 
R4 34.50 ± 0.31 32.79 ± 0.63 34.03 ± 0.58 0.000 0.000 0.000 
R5 33.98 ± 0.52 32.84± 0.64 33.95 ± 3.23 0.000 0.000 0.005 
R6 33.40 ± 1.14 31.55 ± 1.13 33.10 ± 1.55 0.000 0.000 0.000 
R7 33.87 ± 0.79 32.41 ± 0.85 33.70 ± 0.83 0.000 0.000 0.000 
R8 33.72 ± 0.88 32.28 ± 0.87 33.20 ± 0.97 0.000 0.000 0.000 
R9 34.42 ± 0.67 32.99 ± 0.87 33.91 ± 0.69 0.000 0.000 0.000 
R10 33.48 ± 1.03 31.99 ± 1.09 33.00 ± 1.16 0.000 0.000 0.000 
Regarding the thermal symmetry, using the Wilcoxon test, it can be stated that there was 
significant statistical evidence that all thermal symmetry values of each zone were similar 
between moments with the exception of the following ROIs: frontals ROI 4 and ROI 8 between 
moments I and II; frontals ROI 1 and ROI 7 between moments II and III; frontal ROI 4 between 
moments I and III; profile ROI 4 and ROI 7 between moments I and II; profile ROI 4 between 
moments II and III and profile ROI 7 between moments I and III (table 12).  
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Table 12: ROIs thermal symmetry in each moment and the corresponding p-values of Wilcoxon test. 
 
ROIs 1st Moment 2nd Moment 3rd Moment pI-II pII-III pI-III 
F
ro
n
ta
l 
R1 0.20 ± 0.13 0.30 ± 0.15 0.20 ± 0.03 0.206 0.036 0.453 
R2 0.35 ± 0.10 0.40 ± 0.18 0.30 ± 0.15 0.131 0.462 0.280 
R3 0.20 ± 0.04 0.30 ± 0.04 0.20 ± 0.08 0.252 1,000 0.281 
R4 0.10 ± 0.02 0.20 ± 0.06 0.20 ± 0.02 0.014 0.167 0.019 
R5 0.20 ± 0.01 0.10 ± 0.02 0.10 ± 0.01 0.983 0.079 0.141 
R6 0.25 ± 0.26 0.30 ± 0.04 0.30 ± 0.14 0.565 0.145 0.712 
R7 0.25 ± 0.12 0.40 ± 0.08 0.20 ± 0.18 0.051 0.029 0.660 
R8 0.20 ± 0.12 0.33 ± 0.22 0.20 ± 0.11 0.043 0.331 0.441 
R9 0.30 ± 0.07 0.30 ± 0.16 0.30 ± 0.11 0.676 0.575 0.575 
P
ro
fi
le
 
R1 0.85 ± 0.63 0.60 ± 0.48 0.72 ± 0.57 0.408 0.269 0.174 
R2 0.40 ± 0.19 0.45 ± 0.18 0.41 ± 0.34 0.626 0.059 0.308 
R3 0.20 ± 0.07 0.30 ± 0.13 0.20 ± 0.08 0.071 0.085 0.394 
R4 0.20 ± 0.05 0.30 ± 0.08 0.20 ± 0.06 0.008 0.003 0.626 
R5 0.20 ± 0.03 0.15 ± 0.13 0.20 ± 2.86 0.892 0.707 0.883 
R6 0.30 ± 0.05 0.35 ± 0.12 0.30 ± 0.01 0.086 0.247 0.328 
R7 0.25 ± 0.05 0.30 ± 0.13 0.30 ± 0.11 0.009 0.850 0.002 
R8 0.20 ± 0.05 0.20 ± 0.05 0.15 ± 0.03 0.287 0.594 0.081 
R9 0.30 ± 0.16 0.30 ± 0.08 0.25 ± 0.07 0.595 0.434 0.434 
R10 0.40 ± 0.04 0.20 ± 0.05 0.30 ± 0.06 0.086 0.662 0.138 
4.1.2 Oncologic Group 
The approach in this group was to determine whether there were differences in 
temperature surface of skin neoplasms and ΔT in individuals who have been recently 
diagnosed and others, who have been subjected to surgery. In addition to this analysis, an 
attempt to distinguish between benign and malignant neoplasms based in temperature values 
was also performed.  
Table 13 shows that the median temperature in benign neoplasms of diagnosed group was 
approximately 34 ºC, and the malignant neoplasms in follow-up group was around 33.7 ºC. 
Although the median temperatures were slightly different through U Mann-Whitney test, it 
can be settled that the median temperature of benign and malignant skin neoplasms were 
equal in both groups (table 13). 
Table 13: Characterization of median temperature values of skin neoplasms in both groups. 
 
Diagnosed Follow-up 
Right Left Right Left 
Benign 33.03 ± 1.10 34.45 ± 1.19 33.07 ± 0.12 33.03 ± 0.10 
Malignant 33.83 ± 2.17 33.91 ± 2.05 33.68 ± 1.84 33.77 ± 1.70 
U 291.50 279.00 36.00 34.00 
W 1281.50 1269.00 42.00 40.00 
Z -0.300 -0.527 -1.230 -1.320 
p 0.764 0.598 0.219 0.187 
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Considering all individuals in both groups, there was assess if the median temperature of 
benign and malignant skin neoplasm were equal in the follow-up and the skin neoplasm 
groups. Recurring to U Mann-Whitey test, it can be state that the median temperature of 
benign and malign skin neoplasm were similar (table 13). 
Regarding the ΔT in both groups with malignancy, it was assess if the ΔT values were 
equal in the follow-up and the skin neoplasm groups (figure 25). 
 
Figure 25: ΔT values of the benign and malign skin neoplasms in both groups of noplasm. 
Recurring to U Mann-Whitey test, it can be reffered that the ΔTs of benign and malignant 
skin neoplasm were similar in the diagnosed group and different in the follow-up group (table 
14). 
Table 14: Description of U Mann-Whitney test results for the ΔT comparison. 
 
Diagnosed Follow-up 
U 209.500 16.000 
W 314.500 22.000 
Z -1.819 -2.264 
p 0.069 0.024 
The figure 26 illustrates all median ΔT of the different skin neoplasm types regarding its 
malignancy. 
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Figure 26: ΔT values of the different type of skin neoplasms in the differences groups. 
Through the Kruskal-Wallis test, it can be affirmed that the ΔTs values of different skin 
neoplasm types were similar (pD=0.141 and pF=0.204). 
4.1.2.1 Relation between visible skin neoplasms and oncological thermograms 
In the figure 27 are presented some examples of visual images and thermograms of skin 
neoplasms.  
 
 
Figure 27: Thermographic and visual images of some skin neoplasms (A-Melanoma in the back, visual image; B- 
Melanoma in the back, thermogram; C- Melanoma in the scalp, visual image; D- Melanoma in the scalp, thermogram; 
E- Basal Cell carcinoma in face, visual image; F- Basal cell carcinoma in face, thermogram; G- Follow-up of Squamous 
cell carcinoma in face, visual image; H-Follow-up of Squamous cell carcinoma in face, thermogram). 
It can be observed that melanoma is characterized by higher temperatures. On the other 
hand, in follow-up images there was a uniform distribution of superficial temperature. 
 
4.2 Individuals characteristics and skin temperature 
This study was focused in the influence of the individual’s characteristics in the skin 
surface temperature and thermal symmetry for the control group. Relatively to oncologic 
group, it was focused in the skin surface temperature and ΔTs. 
Characteristics, such as gender, body mass index, sun sensibility and in the case of 
females the different phases of menstrual cycle. Age, body mass index and sun sensibility 
were only addressed in oncological group because the control did not have a wide variability 
within this scope. 
4.2.1 Control Group 
In this study it was assessed the gender and phase of the menstrual cycle influence 
between moments for different systems in left and right sides and also in thermal symmetry. 
The group was composed by 24 females and 16 males, while concerning the menstrual cycle, 
14 individuals were in follicular phase and 10 in luteal phase. 
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4.2.1.1 Autonomous Nervous System 
Firsty, it was studied if the gender influences the ANS. It was evaluated if the female and 
male responses were equal at all moments for the right side in frontal and profile positions 
(table 15). 
Table 15: Mean temperatures to the right side of each gender for three different moments. 
 
ROIs Gender 1st Moment 2nd Moment 3rd Moment 
F
ro
n
ta
l 
R1 
F 34.55 ± 0.53 34.55 ± 0.53 34.23 ± 0.77 
M 34.55 ± 2.50 34.04 ± 2.50 34.49 ± 0.37 
R2 
F 34.55 ± 0.72 33.92 ± 0.72 33.71 ± 0.86 
M 34.55 ± 0.52 34.19 ± 0.52 34.29 ± 0.49 
R3 
F 34.55 ± 0.86 33.54 ±0.86 32.77 ± 2.26 
P
ro
fi
le
 
M 34.55 ± 0.78 33.80 ± 0.78 33.74 ± 0.62 
R1 
F 34.55 ± 0.59 32.37 ± 0.71 33.83 ± 0.73 
M 34.55 ± 0.49 32.86 ± 0.43 34.04 ± 0.32 
R2 
F 34.55 ± 0.82 31.72 ± 0.87 32.87 ± 0.89 
M 34.55 ± 0.44 32.91 ± 0.42 34.00 ± 0.42 
R3 
F 34.55 ± 0.84 31.83 ± 0.82 32.98 ± 0.87 
M 34.55 ± 0.60 32.87 ± 0.48 33.94 ± 0.60 
Using U Mann-Whitey test, it can be stated that exists significant statistical evidence to 
affirm that the mean temperatures of frontals ROI R1, ROI R2 and ROI R3 were similar 
between moments I and II. On the other hand, between moments II and III frontals ROI R1 and 
ROI R2 were different. Regarding the profile position, only ROI R1 was equal between 
moment I and II for both genders. Between moments II and III and moments I and III, all ROIs 
were different, with exception to ROI R1 between moment I and III. In table 16 it can be 
observed the p-value, U, W and Z of U Mann-Whitney tests results. 
Table 16: Results of p-value, U, W and Z values of U Mann Whitney test between moments for the right side. 
 
Moment I to II Moment II to III Moment I to III 
U W Z p U W Z P U W Z P 
Fr
o
n
ta
l R1 192 328 0.00 1.000 108 408 -2.34 0.020 166 466 -0.72 0.471 
R2 155 455 -1.02 0.310 110 410 -2.28 0.020 100 400 -2.54 0.011 
R3 158 458 -0.94 0.350 127 427 -1.81 0.070 118 418 -2.06 0.040 
P
ro
fi
le
 R1 154 454 -1.07 0.280 112 412 -2.21 0.030 171 471 -0.60 0.551 
R2 65 365 -3.52 0.000 34 334 -4.36 0.000 37 337 -4.29 0.000 
R3 117 417 0.00 0.040 52 352 -3.88 0.000 69 369 -3.40 0.001 
For left side it was also studied the male and female responses in frontal and profile 
positions (see table 17).  
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Table 17: Mean temperatures to the left side of each gender for three different moments. 
 
ROIs Gender 1st Moment 2nd Moment 3rd Moment 
F
ro
n
ta
l 
R1 
F 34.60 ± 0.55 32.54 ± 0.80 34.23 ± 0.73 
M 34.62 ± 0.40 32.91 ± 0.35 34.41 ± 0.33 
R2 
F 33.94 ± 0.77 32.32 ± 0.84 33.74 ± 0.84 
M 34.10 ± 0.54 32.76 ± 0.52 34.15 ± 0.40 
R3 
F 33.46 ± 0.76 31.78 ± 0.87 33.16 ± 0.91 
P
ro
fi
le
 
M 33.67 ± 0.81 32.30 ± 0.56 33.61 ± 0.64 
R1 
F 34.15 ± 0.53 32.38 ± 0.76 33.75 ± 0.72 
M 34.13 ± 0.58 32.63 ± 0.46 33.90 ± 0.47 
R2 
F 33.47 ± 0.87 31.78 ± 0.93 32.87 ± 0.89 
M 34.23 ± 0.55 32.88 ± 0.47 34.00 ± 0.51 
R3 
F 33.47 ± 0.74 32.02 ± 0.78 33.03 ± 0.80 
M 34.23 ± 0.68 32.94 ± 0.55 33.96 ± 0.61 
Using U Mann-Whitey test it can be referred that there exists significant statistical 
evidence to affirm that the mean temperatures of all ROIs were similar for all moments in 
frontal position with an exception of frontal ROI R1 between moments II and III. For profile 
position all ROIs were different with exception to ROI R1 regarding all moments. In table 18 it 
can be can observed the results for p-value, U, W and Z. 
Table 18: Results of p-value, U, W and Z values of U Mann Whitney test between moments for the left side. 
 
Moment I to II Moment II to III Moment I to III 
U W Z p U W Z P U W Z P 
Fr
o
n
ta
l R1 190 326 -0.04 0.97 117 417 -2.06 0.04 174 474 -0.50 0.62 
R2 178 478 -0.39 0.7 141 441 -1.39 0.16 131 431 -1.68 0.09 
R3 160 460 -0.87 0.38 134 434 -1.59 0.11 130 430 -1.70 0.09 
P
ro
fi
le
 R1 192 328 0.00 1.00 146 446 -1.26 0.21 175 475 -0.46 0.65 
R2 96 396 -2.64 0.01 0.21 345 -4.05 0.00 46 346 -4.03 0.00 
R3 110 410 -2.25 0.02 63 363 -3.56 0.00 64 364 -3.53 0.00 
Regarding thermal symmetry, it was also performed a comparison of genders response in 
frontal and profile positions between moments (table 19). 
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Table 19: Mean temperatures to the thermal symmetry of each gender for three different moments. 
 
ROIs Gender 1st Moment 2nd Moment 3rd Moment 
F
ro
n
ta
l 
R1 
F 0.18 ± 0.15 0.26 ± 0.18 1.63 ± 6.94 
M 0.14 ± 0.12 0.23 ± 0.22 0.18 ± 0.16 
R2 
F 0.25 ± 0.27 0.22 ± 0.15 0.23 ± 0.17 
M 0.22 ± 0.17 0.21 ± 0.12 0.21 ± 0.17 
R3 
F 0.25 ± 0.27 0.35 ± 0.28 0.31 ± 0.21 
P
ro
fi
le
 
M 0.22 ± 0.17 0.21 ± 0.17 0.21 ± 0.18 
R1 
F 0.28 ± 0.26 0.29 ± 0.22 0.29 ± 0.21 
M 0.24 ± 0.20 0.37 ± 0.40 0.27 ± 0.27 
R2 
F 0.26 ± 0.16 0.28 ± 0.23 0.21 ± 0.19 
M 0.20 ± 0.16 0.22 ± 0.21 0.26 ± 0.19 
R3 
F 0.22 ± 0.16 0.26 ± 0.22 0.22 ± 0.14 
M 0.11 ± 0.12 0.18 ± 0.17 0.20 ± 0.18 
Using U Mann-Whitey test, there is a significant statistical evidence the thermal symmetry 
is similar for all ROIs between moments for both genders (see table 20), with exception to 
profile R3 between moment II and III. 
Table 20: Results of p-value, U, W and Z values of U Mann Whitney test between moments for thermal symmetry. 
 
Moment I to II Moment II to III Moment I to III 
U W Z p U W Z P U W Z P 
F
ro
n
ta
l R1 163 299 -0.84 0.4 168 304 -0.66 0.51 147 283 -1.26 0.21 
R2 191 491 -0.01 0.99 186 486 -0.15 0.88 187 323 -0.12 0.90 
R3 165 301 -0.75 0.46 149 285 -1.19 0.23 135 271 -1.56 0.12 
P
ro
fi
le
 R1 178 314 -0.38 0.70 182 482 -0.27 0.79 174 310 -0.50 0.62 
R2 150 286 -1.16 0.24 160 296 -0.88 0.38 157 457 -0.97 0.33 
R3 103 239 -2.46 0.01 145 281 -1.29 0.20 162 298 298.5 0.41 
Later, it was studied the influence of menstrual cycle phase in ANS. To verify if the 
menstrual cycle phases had some impact on the mean temperature on skin surface. It was 
evaluated if the phase’s response were identical at all moments to the right side in frontal 
and profile positions (table 21).  
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Table 21: Mean temperatures to right side of each phase for three different moments. 
 
ROIs Phase 1st Moment 2nd Moment 3rd Moment 
F
ro
n
ta
l 
R1 
1 34,58 ± 0,51 32.72 ± 0.87 34.19 ± 0.86 
2 34.52 ± 0.59 32.27 ± 0.72 34.27 ± 0.65 
R2 
1 34.00 ± 0.62 32.45 ± 0.74 33.73 ± 0.93 
2 33.80 ± 0.86 31.99 ± 0.92 33.68 ± 0.79 
R3 
1 33.67 ± 0.79 31.78 ± 0.89 32.54 ± 2.88 
P
ro
fi
le
 
2 33.37 ± 0.95 31.73 ± 1.74 33.09 ± 0.96 
R1 
1 34.11 ± 0.61 32.54 ± 0.76 33.79 ± 0.82 
2 34.00 ± 0.60 32.13 ± 0.59 33.88 ± 0.63 
R2 
1 33.5 ± 0.82 31.88 ± 0.78 32.84 ± 0.93 
2 33.33 ± 0.86 31.50 ± 0.98 32.91 ± 0.87 
R3 
1 33.71 ± 0.91 31.98 ± 0.7 32.90 ± 0.92 
2 33.55 ± 0.77 31.61 ± 0.96 33.04 ± 0.84 
Using U Mann-Whitey test, it can be affirm that in both frontal and profile positions the 
mean temperatures of right side were similar for all moments in different phases. In appendix 
V it can be found the results for p, U, W and Z values. After, it was evaluated if the response 
of the first and second phases were equal at all moments to the left side in frontal and 
profile positions (see appendix VI). Using U Mann-Whitney test it can be affirm that the mean 
temperatures are equal for all moments for both phases. The results can be observed in 
appendix VI. 
Table 22: Mean temperatures to thermal symmetry of each phase for three different moments. 
 
ROIs Phase 1st Moment 2nd Moment 3rd Moment 
F
ro
n
ta
l 
R1 
1 0.17 ± 0.17 0.28 ± 0.14 0.22 ± 0.21 
2 0.18 ± 0.12 0.23 ± 0.23 0.20 ± 0.12 
R2 
1 0.25 ± 0.32 0.22 ± 0.14 0.25 ± 0.18 
2 0.26 ± 0.17 0.21 ± 0.17 0.19 ± 0.15 
R3 
1 0.29 ± 0.27 0.33 ± 0.27 0.30 ± 0.23 
P
ro
fi
le
 
2 0.26 ± 0.19 0.37 ± 0.31 0.33 ± 0.20 
R1 
1 0.34 ± 0.31 0.26 ± 0.20 0.24 ± 0.23 
2 0,20. ± 0.13 0.32 ± 0.25 0.36 ± 0.18 
R2 
1 0.19 ± 0.15 0.27 ± 0.18 0.18 ± 0.17 
2 0.34 ± 0.12 0.30 ± 0.29 0.26 ± 0.21 
R3 
1 0.24 ± 0.12 0.20 ± 0.16 0.22 ± 0.13 
2 0.19 ± 0.16 0.35 ± 0.27 0.21 ± 0.15 
Finally, it was evaluated the influence of menstrual phases in thermal symmetry. The 
results can be observed in table 22 for all moments. 
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Table 23: Results of p-value, U, W and Z values of U Mann Whitney test between moments for thermal symmetry. 
 
Moment I to II Moment II to III Moment I to III 
U W Z P U W Z P U W Z p 
Fr
o
n
ta
l R1 64 169 -0.36 0.71 50 105 -1.16 0.24 59 114 -0.66 0.50 
R2 55 160 -0.85 0.39 65 120 -0.26 0.79 56 111 -0.82 0.41 
R3 69 124 -0.05 0.95 67 172 -0.14 0.88 65 170 -0.26 0.79 
P
ro
fi
le
 R1 48 103 -1.28 0.19 60 165 -0.56 0.57 44 149 -1.51 0.13 
R2 29 134 -2.38 0.01 68 123 -0.11 0.90 57 162 -0.73 0.46 
R3 59 114 -0.64 0.51 49 154 -1.20 0.22 62 117 -0.44 0.65 
Using U Mann-Whitey test, it can be stated that there exists significant statistical 
evidence to affirm that thermal symmetries were equal for all ROIs in all moments with 
exception to profile ROI R2 between moment I and II (see table 23). 
4.2.1.2 Microvascular System 
In this system it was also studied the influence of gender and phase of menstrual cycle. 
Firstly, it was evaluated if the response of the female and male genders were equal at all 
moments for the right side in frontal and profile positions (see appendix VII). By U Mann-
Whitey test it can be stated that there exist significant statistical evidence to affirm that 
between moment I and II, all temperatures of all ROIs were similar, with exception to frontal 
ROI R9 and profile ROIs R6, R7, R8 and R10. Between moments II and III, all temperatures of 
all ROIs were equal, with exception to frontal R1, R4, R6, R7 and R9 ROIs and profile R1, R3, 
R6, R7, R8, R9 and R10 ROIs (see appendix VII). Finally, between moments I and III, all 
temperatures were similar, with exception of frontal R1, R6 and R9 ROIs and profile R1, R2, 
R6, R7, R8, R9 and R10 ROIs. 
Regarding the left side, it was performed the same study (appendix VIII). Using U Mann-
Whitey test it can be stated that there exist significant statistical evidence to affirm that all 
temperatures were similar between moments I and II, with exception to ROIs frontal R5 and 
R9, and profile R6, R7, R8 and R10. Between moments II and III, all temperatures were 
identical with exception to frontal R1, R6, R7 and R9 and profile R1, R6, R7, R8, R9 and R10. 
In sum, between moments I and III all temperatures were equal with exception of profile R1, 
R3, R6, R7, R8, R9 and R10 and frontal R6, R7 and R8 (appendix VIII). 
Relatively to thermal symmetry, the same study was performed, also in frontal and 
profile positions (appendix IX). Using the U Mann-Whitey test it can be referred that there is 
significant statistical evidence to affirm that the thermal symmetries were similar for all ROIs 
in all moments, with exception to profile ROI R3 between moments I and II, frontal R3 and R7 
and profile R1, R7 and R8 ROIs between moments II and III. Between moments I and III, only 
frontal R3 and profile R1 and 7 ROIs were different (see appendix IX). 
Secondly, it was studied the influence of menstrual cycle phases in MS in profile and 
frontal positions (appendix X). Using U Mann-Whitey test it can be stated that there is 
significant statistical evidence to affirm that the temperatures of right side were equal for all 
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ROIs in all moments, both profile and frontal positions with exception of frontal ROI R8 
between moments II and III. The results can be observed in appendix X. Using U Mann-Whitey 
test, it can be referred that there is significant statistical evidence to affirm that the 
temperatures of left side were identical for all ROIs in all moments in both profile and frontal 
positions (appendix XI). 
The thermal symmetry response of different phases in each moment for frontal and 
profile positions was assess using U Mann-Whitney test (appendix XII). Through this test it can 
be stated that there is significant statistical evidence to affirm that thermal symmetry are 
similar for all ROIs in all moments, with exception to profile ROI R3 between moments I and II 
and frontal ROI R9 between moments II and III and between moments I and III. The results can 
be observed in appendix XII. 
4.2.2 Oncologic Group 
For oncologic group, it was studied the influence of individuals characteristics such as 
gender, age, BMI, sun sensibility and malignancy in ΔT and mean temperature. In relation to 
diagnosed group, all mentioned characteristics were studied. Concerning the gender, it were 
recorded 26 females and 32 males. For malignancy, it were recorded 14 benign skin 
neoplasms and 44 malignant neoplasms of the diagnosed group. The distribution of individuals 
in each BMI class for diagnosed group was 1 individual bellow age of 18.5, 20 individuals in 
class ]18.5-25], 28 individuals in class ]25-30] and 9 individuals in class ]30-35]. The 
distribution in each subject age was 3 individuals in class [18-30], 2 individuals in class ]30-
40], 2 individuals in class ]40-50], 4 individuals in class ]50-60], 18 individuals in class ]60-70] 
and 29 individuals with age higher than 70. For sun sensibility, were recorded 6 individuals in 
class ]10-20], 22 individuals in class ]20-30] and 30 individuals in class ]30-40]. The obtained 
results for each characteristic were in table 24. 
Regarding to follow-up group, it were recorded 24 females and 21 males. For malignancy, 
it were recorded 3 benign skin neoplasms and 42 malignant neoplasms of the diagnosed 
group. The distribution of individuals in each BMI class for the diagnosed group was 16 
individuals in class ]18.5-25], 19 individuals in class ]25-30], 8 individuals in class ]30-35] and 
2 individuals with BMI higher than 35. The distribution in each subject age was 3 individuals in 
class [18-30], 1 individuals in class ]30-40], 3 individuals in class ]40-50], 7 individuals in class 
]50-60], 10 individuals in class ]60-70] and 21 individuals with age higher than 70. 
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Table 24: Obtained results for each characteristic to median temperatures of aright and lefts sides and ΔTs for 
diagnosed group. 
 
Classes Right Left ΔT 
Subject Age 
[18,30] 33.00 ± 1.48 33.00 ± 1.34 0.00 
]30,40] 33.00 ± 0.00 32.90 ± 0.00 0.10 ± 0.00 
]40,50] 33.70 ± 2.47 33.60 ± 2.28 0.10 ± 0.01 
]50,60] 34.40 ± 5.00 34.30 ± 4.79 0.10 ± 0.02 
]60,70] 34.15 ± 4.48 34.25 ± 2.10 0.10 ± 0.79 
>70 33.80 ± 2.64 34.00 ± 2.73 0.20 ± 0.05 
Subject Gender 
Female 33.55 ± 4.41 33.90 ± 3.69 0.20 ±0.33 
Male 34.10 ± 1.28 34.10 ± 1.35 0.10 ±0.04 
BMI 
]18,5;25] 34.45 ± 3.74 34.25 ± 2.24 0.10 ± 0.48 
]25,30] 33.80 ± 1.62 34.00 ± 1.54 0.10 ± 0.07 
]30,35] 32.90 ± 4.56 32.75 ± 4.59 0.15 ± 0.01 
<35 34.05 ± 0.61 34.05 ± 0.13 0.30 
Sun Sensibility 
]10,20] 33.00 ± 0.00 32.90 ± 0.00 0.10 ± 0.00 
]20,30] 34.40 ± 5.72 34.20 ± 4.76 0.10 ± 0.43 
]30,40] 33.75 ± 1.50 33.95 ± 1.43 0.10 ± 0.05 
Malignancy 
Benign 33.00 ± 0.01 33.00 ± 0.02 0.00 
Malign 34.15 ± 3.39 34.05 ± 2.90 0.10 ± 0.21 
For sun sensibility, it were recorded 1 individual in class ]10-20], 18 individuals in class 
]20-30] and 26 individuals in class ]30-40]. The obtained results for each characteristic are 
presented in table 25. 
Table 25: Results follow-up group characteristic to right and lefts sides and ΔT. 
Characteristics Classes Right Left ΔTs 
Subject Age 
[18,30] 33.00 ± 1.48 33.00 ± 1.34 0.00 
]40,50] 33.70 ± 2.47 33.60 ± 2.28 0.10 ± 0.01 
]50,60] 34.40 ± 5.00 34.30 ± 4.79 0.10 ± 0.02 
]60,70] 34.15 ± 4.48 34.25 ± 2.10 0.10 ± 0.79 
>70 33.80 ± 2.64 34.00 ± 2.73 0.20 ± 0.05 
Subject Gender 
Female 33.55 ± 4.41 33.90 ± 3.69 0.20 ±0.33 
Male 34.10 ± 1.28 34.10 ± 1.35 0.10 ±0.04 
BMI 
]18,5;25] 34.45 ± 3.74 34.25 ± 2.24 0.10 ± 0.48 
]25,30] 33.80 ± 1.62 34.00 ± 1.54 0.10 ± 0.07 
]30,35] 32.90 ± 4.56 32.75 ± 4.59 0.15 ± 0.01 
>35 34.05 ± 0.61 34.05 ± 0.13 0.30 
Sun Sensibility 
]10,20] 33.00 ± 0.00 32.90 ± 0.00 0.10 ± 0.00 
]20,30] 34.40 ± 5.72 34.20 ± 4.76 0.10 ± 0.43 
]30,40] 33.75 ± 1.50 33.95 ± 1.43 0.10 ± 0.05 
Malignancy 
Benign 33.00 ± 0.01 33.00 ± 0.02 0.00 
Malign 34.15 ±3.39 34.05 ± 2.90 0.10 ± 0.21 
It was studied if ΔT was related to these characteristics for both groups. For diagnosed 
group, with the aid of U Mann-Whitney test it can be stated that there is statistical significant 
evidence to affirm that the ΔTs referring to malignancy were different (table 26). 
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Table 26: U Mann Whitney test results in terms of p-value and ranking values for diagnosed group. 
Characteristics U W Z P 
Gender 171.00 402.00 1.94 0.05 
Malignancy 16.00 22.00 2.26 0.02 
Within diagnosed group, using Kruskal-Wallis test there is statistical significance evidence 
to affirm that the ΔTs were different for the BMI classes (table 27). 
Table 27: Kruskal-wallis test results in terms of p-value for diagnosed group. 
Characteristics p 
Age 0.33 
BMI 0.00 
Sun Sensibility 0.53 
For the follow-up group, using U Mann-Whitney test there is statistical significance 
evidence to affirm that the ΔTs referring to gender and malignancy were identical (table 28). 
Table 28: U Mann Whitney test results. 
Characteristics U W Z P 
Gender 343 694 1.15 0.25 
Malignancy 209 314 1.82 0.07 
Using Kruskal-Wallis test there is statistical significance evidence to affirm that the ΔTs 
were different in BMI classes (table 29). 
Table 29: Kruskal-wallis test results in terms of p-value. 
Characteristics P 
Age 0.51 
BMI 0.04 
Sun Sensibility 0.64 
 
4.3 Individuals characteristics and malignancy 
The fourth part of this study is focused on establishing relations between individual’s 
characteristics and malignancy. Characteristics such age, gender, body mass index, sun 
sensibility and family history. 
It was verified that 83.3% of individuals are within 18 to 30 years old and were benign 
neoplasms. The prevalence of malign neoplasms was the age group of 40 to 70 years old is 
also noteworthy (see table 30). Using Pearson chi-square test can be stated that there is 
statistical significant evidence that the age and malignancy are associated. 
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Table 30: Prevalence of malignancy by age classes. 
 
[18,30] ]30,40] ]40,50] ]50,60] ]60,70] >70 p 
N % N % N % N % N % N % 
Benign 5 83.3% 2 66.7% 0 0.0% 1 9.1% 4 14.3% 5 100% 
0.00 
Malign 1 16.7% 1 33.3% 5 100.0% 10 90.9% 24 85.7% 45 90.0% 
A percentage of 14% of female individuals had benign neoplasms (table 31). With Pearson 
chi-square test, it can be stated that there is no statistical significant evidence that the 
gender is related with malignancy. 
Table 31: Prevalence of malignancy in gender. 
 
Female Male P 
N % N % 
Benign 7 14.0% 10 18.9% 
0.506 
Malign 43 86.0% 43 81.1% 
A percentage of 5.9% of individuals who had BMI less than 18.5 kg/m2 had benign 
neoplasms. Whereas 44.2% of individuals with BMI between 25 and 30 kg/m2 had malignant 
neoplasms (table 32). Using Pearson chi-square test there is statistical significant evidence to 
affirm that the BMI classes and malignancy are not associated. 
Table 32: Prevalence of malignancy by BMI classes. 
 
<18,5 ]18,5;25] ]25,30] ]30,35] >35 P 
N % N % N % N % N % 
Benign 1 5.9% 6 35.3% 9 52.9% 1 5.9% 0 0.0% 
0.131 
Malign 0 0.0% 30 34.9% 38 44.2% 16 18.6% 2 2.3% 
A percentage of 26.8% of individuals who had a sun sensibility between 30 and 40 points 
had benign neoplasms. However, 97.5% of individuals, who had a sun sensibility between 20 
and 30 points had malignant neoplasms (table 33). Using Pearson chi-square test, it can be 
stated that there is statistical significant evidence that the sun sensibility is related with 
malignancy. 
Table 33: Prevalence of malignancy by sun sensibility classes. 
 
]10,20] ]20,30] ]30,40] P 
N % N % N % 
Benign 1 14.3% 1 2.5% 15 26.8% 
0.007 
Malign 6 85.7% 39 97.5% 41 73.2% 
A percentage of 50% of individuals who had family history with paternal relatives had 
benign neoplasms. Similarly, 50% of individuals who had family history with paternal relatives 
had malignant neoplasms. It should also be noted that 20% of individuals who had family 
history with a sibling had benign neoplasms, while 80% of individuals who had family history 
with a sibling had malign neoplasms (figure 28). Thus, using Pearson chi-square test, it can be 
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affirmed that exists statistical significant evidence that the family history is not related with 
malignancy (p=0.457). 
 
Figure 28: Illustration of the malignancy prevalence with family history. 
 
4.4 Case Study – Basal cell carcinoma 
Another study was performed to investigate whether the ΔT value of individuals with 
basal cell carcinoma in the diagnosed and control group were identical. Four case studies of 
basal cell carcinoma were studied. 
 
Figure 29: ΔT illustration in the different case studies. 
It can be observed in the figure 29 that the ΔT values that stand out correspond to the 
control groups with the exception of case study I, where the diagnosed individual has a fairly 
high ΔT. 
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Table 34: Results of U Mann-Whitney test. 
 
CS I CS II CS III CS IV 
U 0 0.5 0.5 2.5 
W 105 1.5 1.5 3.5 
Z -1.639 -1.571 -1.553 -1.184 
p 0.101 0.116 0.12 0.236 
Using U-Mann Whitney test, it can be affirmed that exists significant statistical evidence 
that the ΔT values of basal cell carcinoma asymptomatic individuals is similar in all case 
studies (table 34). 
 
4.5. Summary considerations 
The global obtained results showed that the median temperatures between moments of 
ANS and MS in the control group were different in the majority of ROIs. On the other hand, 
the thermal symmetry was always similar for the ANS, noting some differences in the MS. 
Relatively to oncological skin surface characterization, it was not found differences in the 
mean temperatures of the right and left sides, neither between the ΔTs of different types of 
skin neoplasms. However, there are significant differences in the ΔTs of the follow-up group.  
When it was studied the influence of the individual’s characteristics in skin surface, there 
was always differences in gender of ANS for the right side, while for the left side there was 
the opposite. For the MS there were no differences for both sides. With respect to menstrual 
phase, there was no statistical evidence for both systems.  
Finally, it was concluded that BMI characteristic influenced the ΔT of oncologic group, 
while the malignancy also influenced the ΔT of diagnosed group. 
  
Chapter 5.  
Discussion 
In this chapter the reader will find a discussions on the facial skin surface temperature 
characterization, the influence of individual characteristics in facial skin surface 
temperature, the relationship between individual characteristics with the neoplasm 
malignancy. 
 
5.1 Skin surface temperature characterization 
The first study consisted in an exploratory data analysis of a control group in order to 
characterize the temperature at the skin surface of the face (most affected region with skin 
neoplasms) in the autonomous nervous system (ANS) and microvascular system (MS). This 
study considered the intervention of a thermal stimulus in order to evaluate the physiological 
response of the face skin surface. It was found that the mean temperature of zones between 
moments was significantly different. There were always differences between the first and the 
second moments, as it would be expected with the application of a cold stimulus, similar 
effect was found at third moment. There was a decline in temperature of approximately 2ºC 
in the ANS and 1.5ºC in the MS due to the thermal stimulus. It means that the exposure time 
period of two minutes used to cool the face surface with the fan was adequate. After 
applying the stimulus, the autonomic nervous system reacts, trying to prevent a drop in body 
temperature and readjusting the temperature to its normal levels (homeostasis) correcting 
the caused disequilibrium. From the second to the third moments there was a clear increase, 
due to the response of the thermoregulatory system in order to restore the temperature 
levels. It would be expected that mean temperatures between the first and the third 
moments to be similar. Despite this fact, there is a small difference of approximately 0.5 °C 
between the temperature values of the two moments. Which means that the third moment 
should be longer than 5 minutes to allow for null recovery.  
Performing a deeper analysis, in the ANS it was worth noticing that frontal ROI R2 did not 
register any difference in the mean temperatures between moment I and II for left and right 
sides. Similarly in the MS the frontal ROI R2 between moment I and III had no differences in 
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mean temperatures. These results may be due to the fact that in this area of the face being 
located a large amount of adipose tissue.  
Within this group it was also studied the influence of thermal symmetry in both systems. 
In ANS, all thermal symmetries were identical, with exception to frontal ROI R1 between 
moment I and II and between moments I and III. To MS, the majority of thermal symmetries 
were similar, excluding ROI R4 and ROI R7 in frontal and profile positions. These results may 
be due to poor performance of the fan for ROI R4, or individuals with non-acknowledged 
teeth condition for ROI R7. Finally, it was calculated the mean thermal symmetries for each 
system. The ANS presented a mean thermal symmetry of approximately 0.23ºC while MS 
unveiled a mean thermal symmetry of approximately 0.35ºC. These values are only suggestive 
and exploratory. However, they were in agreement with the literature values [99, 100]. 
Relatively to the oncologic group, it would be expected that, the benign neoplasms 
exhibit lower temperature than malignant neoplasms, since the greater the degree of 
inflammation, the higher temperature would be expected in that zone. These results may 
have been due to an absence of inflammatory processes in the malignant neoplasms at the 
time of imaging.  
It was also expected that newly diagnosed neoplasms, demonstrating higher temperature 
values when compared to patients who were surgically intervened. Although in some cases 
this was verified, at a global analysis there are no relevant differences. After this, the mean 
temperatures of the various types of skin neoplasms were investigated for the oncologic 
group and the conclusions were confirmed. All types of studied skin neoplasms had equal 
mean temperatures for the different sides. These values may have been different if the 
thermographic examination was complemented with the application of a provocative test, 
similar to the thermal stimulus that was applied to the control group. Some authors [83], [86] 
argue that thermal stimulation solves the problems of false negatives provided by medical 
thermography. In the case of malignant neoplasms, when the area of the skin is cooled, an 
hypertermic manifestation is expected in the middle of the neoplasm, followed by a fast 
thermal recovery of the neoplasm tissue when compared with the surroundings. The thermal 
challenge was not applied in this research study with the oncological group due to 
operational constraints, such as the reconstructive plastic surgery consults had to last 
between 3 and 10 minutes and there was no extra examination room where the experiments 
could take part. Another approach that could have been used in an attempt to overcome the 
presented difficulties, was in the images analysis, to draw two diagonals over the skin 
neoplasm, named D and D’ (figure 30) with a fixed number of points and to calculate a vector 
V through these following formula: 𝑉𝑖
𝑁  = 𝐷𝑖
𝑁 . 𝐷′𝑖
𝑁. 
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Figure 30: Example of diagonals on skin neoplasm. 
Thus, it would be possible to plot a temperature profile along the skin neoplasm, and through 
the shape of V would be obtained more important and conclusive information, that could 
characterize it. Although it was not possible to the short time available. 
In the oncological group, the influence of ΔT values was also investigated. The ΔT values 
of benign and malign skin neoplasms were equal in the diagnosed group and different in the 
follow-up group. These differences may be due to reading error of the thermographic 
camera, approximately 0.3 ºC (2% of the overall reading). 
 
5.2 Individual characteristics and skin temperature 
Different results were obtained when it was tested the influence of the individual 
characteristics in skin surface temperature. In the control group, the influence of individual 
age, sun sensibility and BMI was not tested, because this group had a narrow interval of these 
characteristics. With regard to the gender, it was found that the mean temperatures were 
similar for both genders in most of the ROIs. For the ANS, profile ROIs R2 and R3 had 
significant differences for right and left sides. In the MS, the same can be stated for frontal 
ROIs R6, R7 and R9 and profile ROIs R6, R7, R8, R9 and R10 for both sides. Relatively to 
thermal symmetry the emphasis was to the ANS profile ROI R3 between moment II and III. For 
MS there was greater variability of significant ROIs. Worth mention that profile ROIs R1, R6, 
R7 R8 and R9 for their repetitiveness. It was concluded that in these specific areas the 
different genders do not react the same way for both systems, as it would be expected since 
there are facial gender differences. Similar results were obtained when testing the influence 
of the menstrual cycle phase. For both systems, the mean temperatures were similar in the 
different phases and for each moment. One exception was found for frontal ROI R8 for right 
side of MS between moments II and III. Few exceptions were found when the thermal 
symmetry was evaluated. For the ANS there were differences in profile ROI R2 between 
moments I and II and for MS. It can be underlined that the frontal ROI R9 between moments II 
and III, and between moments I and III, TS's were different. In the luteal phase there is a 
higher basal body temperature since there is a substantial increase in the production of 
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progesterone. These results may have been due to the difficulty to know the menstrual cycle 
phase of few individuals. 
It was also studied if the individual characteristics have an impact on ΔT of the follow-up 
and skin neoplasms groups. For diagnosed group, it was found that the skin neoplasms type 
and BMI had impact on ΔT. For the follow-up group, only BMI had impact. Further 
characteristics such as gender, sun sensibility and age were not significant. The sun 
sensibility is only an indicative feature for high or low risk of skin neoplasms, not being 
related with the ΔT. 
 
5.3 Individuals characteristics and malignancy 
Various characteristics were tested to establish a relation with the neoplasm type. With 
respect to age, this is related to the neoplasm type, since older people (> 40 years) are more 
likely to develop malignant neoplasms, whereas younger people (<30 years) are more likely to 
develop benign neoplasms. This result was entirely related to prolonged sunlight exposure for 
many years. This means that people tend to develop malignancies in adulthood. 
On the other hand, it can be concluded that the gender is not related to the neoplasm 
type. These results suffer from selection bias because it was not considered the same number 
of individuals for different genders. The physician collaborating with this study referred that 
these diseases are more prevalent in the male gender because they usually have professions 
with much more prolonged sun exposure.  
Furthermore, it was also found that BMI is not related to the neoplasm type, it can be 
accepted since there are people with different weights and heights, developing neoplasms. 
However, in the literature [114] there is a relationship between obese (BMI> 30) and the 
development of nonmelanoma skin cancer. In the current study sample there was a high 
incidence of malignancies in pre-obese, 24.9<BMI<30). There was a small incidence of people 
being obese, but mostly in pre-obesity.  
The sun sensibility is found to be related to the neoplasm type. A very sun sensibility 
person (light skin, light hair, light eyes and has freckles) develops burns much faster, more 
severe and deeper than a less sun sensibility person, increasing the risk of developing 
malignancies later. 
Family history is unrelated to the skin neoplasms type. Although the literature [5] says 
that melanoma may be hereditary. It cannot be concluded from this study, since the number 
of screened melanomas was too small and the vast majority of participants have no 
melanoma family history. Later, it was found that many of them were not aware, this may be 
due to the high number of family members, disease illiterate or even memory problems. 
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5.4 Case studies 
The results obtained for the case studies allowed to conclude that ΔT of the skin 
neoplasm individual and associated control group were similar for diagnosed group. However, 
this result is contrary to the literature [95]. Many studies shows that in the case of basal cell 
carcinoma had higher metabolism, increasing blood flow and presented slightly higher 
temperature when compared to surrounding healthy skin. Therefore, it should have been 
obtained higher temperatures in the basal cell carcinoma participants than in the control 
group. However, to the results being more accurate and precise, a larger dimension sample 
of basal cell carcinoma participants is needed. 
 
  
  
Chapter 6.  
Conclusion  
The aim of this research study was the characterization of the temperature at the skin 
surface in healthy control and skin oncologic groups, which was fully accomplished. It was 
also assessed the effect of age, BMI, gender, sun sensibility, malignancy, menstrual cycle 
phase in females, thermal symmetry and ΔTs in the studied population.  
Reference data was provided for facial temperature distribution in autonomous nervous 
system and microvascular system. 
The characteristic factors that had a significant relationship were the BMI for the 
diagnosed and follow-up groups, and the malignancy factor in the diagnosed group. 
It can be concluded that medical thermal imaging proved its importance in the support 
for the identification and assessment of the skin carcinoma treatments. However, it requires 
significant research improvements and more tests with large samples in order to be actually 
used as a complementary method of diagnosis in the field of dermatology. Nevertheless, 
there were many limitations in this study that could affect the global results: 
 It was not impossible to perform the thermo-stimulus in the oncologic group, due 
to the reduced appointment time for each individual (less than 10 minutes) and 
the inexistence of a free examination room; 
 The impossibility of measure the height and weight of the individuals involved in 
this study, and thus not accurate. 
 
6.1 Proposed future work 
In order to take this work into a further step, the following future work is proposed: 
 Build a larger dataset to yield more diverse in order to have more statistical evidence 
results;  
 Develop an efficient cold stimulus for better understanding of the thermophysiology of 
the skin surface and associated characteristics; 
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 Development of a dedicated software for standardizing the image analysis in order to 
improve the reproducibility and accuracy of the method.  
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Appendix II: Volunteers information 
INFORMAÇÃO AOS VOLUNTÁRIOS 
Projeto de investigação: Caracterização de Neoplasias de pele através de Termografia 
Médica normalizada. 
Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. 
Faculdade de Engenharia da Universidade do Porto 
 
1. O porquê deste projeto de investigação? 
Este projeto pretende investigar a utilização da termografia médica na avaliação 
fisiológica tanto na identificação, como na monitorização dos tratamentos dos melanomas 
(tipo de cancro da pele) na zona onde estiver presente a lesão. Os resultados deste projeto 
permitirão efetuar estudos de maior dimensão na área dos melanomas e em outras regiões de 
interesse do corpo humano, possibilitando conhecer melhor a sua fisiologia, encaminhamento 
para tratamentos mais eficazes, e consequentemente, levar à redução substancial dos custos 
associados a esta patologia. 
 
2. O que é um termograma? 
 
Um termograma é uma imagem da temperatura da pele. Tal pode ser observado nas 
figuras exibidas em baixo, que representam termogramas da face frontal e lateral, 
respetivamente. 
 
 
Estas imagens são obtidas através de captura por parte de câmaras termográficas, das 
perdas de calor naturais que acontecem à superfície da pele. É um procedimento não-
invasivo, inofensivo e indolor, sendo que as fotografias são adquiridas do mesmo modo que o 
método convencional. As imagens recolhidas vão ser usadas para fins médicos e académicos, 
sendo que os dados de cada paciente irão ser preservados e mantidos confidenciais, assim 
como toda a informação irá ser gravada de modo seguro. É impossível identificar um 
indivíduo através de um termograma, sem que a identificação esteja associada ao mesmo.  
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3. O que é um melanoma? 
 
Os melanomas são um tipo de cancro que atinge o tecido epitelial, tendo origem nos 
melanócitos, células localizadas na epiderme, que são responsáveis pela produção de 
melanina, pigmento que dá à pele a sua cor natural. Têm grande capacidade de metastizar 
de forma rápida, num estadio da doença relativamente precoce. O melanoma surge quando 
os melanócitos (células pigmentares), adquirem o estado maligno. Os melanomas são o 
terceiro tipo de cancro da pele mais comum, que afeta pessoas de todas as faixas etárias. 
Embora o melanoma seja a maior causa de morte de cancro da pele, se este for detetado 
num estadio precoce pode ser curável. 
 
4. O que necessito que faça para participar neste projeto? 
 
Venho por este meio, pedir a sua colaboração num projeto de investigação simples e 
rápido, onde apenas serão retiradas algumas fotografias (uma ou duas) da zona onde poderá 
estar presente a lesão. Este processo envolve várias etapas. 
Necessito que antes da captura das fotografias, o indivíduo permaneça numa sala 
climatizada, expondo a área onde poderá estar a lesão, com o intuito de a mesma obter a 
temperatura pretendida. Este processo demora cerca de 10 minutos. Enquanto isso, o 
individuo deverá preencher e tomar conhecimento de alguns formulários. Entre estes 
incluem-se, o consentimento informado, questionário de dados biométricos, e questionário 
associado à patologia. O questionário de dados biométricos permite conclusões acerca de 
problemas relacionados com mobilidade, autonomia, atividades normais, desconforto/dor e 
também ansiedade/depressão. A pontuação final obtida neste questionário deverá ser igual a 
zero, para inclusão do indivíduo no projeto. Também é indispensável que este tenha o seu 
índice de massa corporal (IMC) calculado. Este é um cálculo relativamente simples, bastando 
para tal dividir a massa por duas vezes a altura. Esta informação é utilizada para agregar os 
indivíduos com IMC semelhante. 
No dia das recolhas algumas precauções deverão ser tomadas antes do período de 
recolha, tais como: 
 Não ingerir uma refeição pesada; 
 Não participar em atividades cansativas e desgastantes; 
 Não ingerir bebidas alcoólicas e fumar, num período até duas horas antes de as 
imagens serem recolhidas; 
 Deverá ser usado o mínimo vestuário possível para se obterem termogramas claros; 
 Remover todo o tipo de bijuteria e relógios durante o período de captura; 
 Não aplicar à pele qualquer tipo de creme corporal; 
 Por fim, permanecer estático nas posições solicitadas pelo investigador para o 
procedimento de captura. 
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5. Quanto tempo vai durar? 
A participação de cada indivíduo neste projeto irá demorar aproximadamente 15 minutos 
(incluindo o tempo de descanso). As recolhas deverão ser feitas quando for da sua 
conveniência. 
 
6. Vou ser pago pela minha participação? 
Infelizmente, o financiamento é limitado, pelo que não irá receber qualquer pagamento 
pela sua participação neste estudo. Contudo, irá contribuir significativamente para 
desenvolvimentos únicos e importantes na área da utilização da termografia médica na 
dermatologia. Após a participação, chocolates e rebuçados serão oferecidos como sinal de 
gratidão. As imagens recolhidas poderão também ser enviadas via email caso sejam 
solicitadas pelo voluntário. 
 
7. Contacto 
 
Nome: Liliana Vasconcelos Esteves 
Instituição: Faculdade de Engenharia da Universidade do Porto 
email:bio12086@fe.up.pt ou lilianavasconcelosesteves@gmail.com 
telemóvel:918611971 
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Appendix III : Consent Form 
Consentimento Informado 
Considerando a "Declaração de Helsínquia", da Associação Médica Mundial 
(Helsínquia 1964; Tóquio 1975, Hong Kong 1989; Somerset West 1996; Edimburgo 
2000; Washington 2002, Tóquio 2004 e Seoul, 2008) 
 
Designação do projeto de investigação 
Análise de melanomas através de Termografia Médica normalizada e automatizada 
Eu, abaixo-assinado (nome completo do doente adulto ou do voluntário são) 
_________________________________________________________________________________________
_________________________________________________________________ 
Recebi o texto de Informação ao Participante relativo ao procedimento que concordei efetuar. 
Compreendi a explicação que me foi fornecida pelo investigador que assina este documento. Foi-me 
ainda dada oportunidade de fazer as perguntas que julguei necessárias, e de todas obtive resposta 
satisfatória. 
Tomei conhecimento de que, de acordo com as recomendações da Declaração de Helsínquia, a 
informação ou explicação que me foi prestada versou os objetivos, os métodos, os benefícios previstos, 
os riscos potenciais e o eventual desconforto. Além disso, foi-me afirmado que tenho o direito de anular 
a todo o tempo a minha participação no estudo, sem que isso possa ter como efeito qualquer prejuízo 
na assistência que me é prestada. 
Por isso, consinto que me seja aplicado o método, o tratamento ou o inquérito proposto pelo 
investigador. 
Assinatura do doente ou voluntário são: __________________________Data: ___/___/201_ 
Nome do Investigador responsável:___________________________ Data: ___/___/201_ 
Assinatura do Investigador responsável:__________________________ Data: ___/___/201_ 
 
Anulação do Consentimento Informado 
Declaro que recebi a Informação ao Participante relativo ao projeto de investigação em questão, 
que me foi proposto pelo investigador que assina este documento e pretendo anular o consentimento 
dado na data ___/___/201_. 
 
Assinatura do doente ou voluntário são: __________________________Data: ___/___/201_ 
Assinatura do Investigador responsável: __________________________Data: ___/___/201_ 
 
Nota: Fornecimento obrigatório de cópia ao participante. 
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Appendix IV : Questionnaire 
Questionário de dados biométricos 
 
Preencha o questionário abaixo indicado, de forma a avaliar o estado de saúde dos voluntários 
participantes neste estudo.  
Nome: ____________________________________________________ 
Género:    Feminino               Masculino Outro  
Peso: _____________________ 
Idade:_____________________ 
Altura:_____________________ 
Índice de massa corporal:_____________ 
Lesões ou cirurgias realizadas nos últimos meses:  Sim                      Não     
Se respondeu sim, há quanto tempo? ________ 
Pontuação:____________ 
 
De acordo com os tópicos abaixo descritos, por favor assinale aquele com qual se identifica. 
 
Mobilidade 
Não tenho problemas em caminhar  
Tenho alguns problemas ao caminhar  
Estou de cama  
Autonomia 
Não costumo ter problemas no dia à dia  
Tenho alguns problemas em tarefas como lavar-me e vestir-me  
Sou incapaz de realizar tarefas como lavar-me ou vestir-me  
Actividades normais 
Não tenho problemas na realização das tarefas normais (trabalhar, estudar etc.)  
Tenho alguns problemas na realização das tarefas normais (trabalhar, estudar etc...)  
Sou incapaz de realizar as tarefas normais  
Desconforto/Dor 
Não tenho nenhuma dor ou desconforto  
Tenho dor moderada ou desconforto  
Tenho extrema dor ou desconforto  
Ansiedade/Depressão 
Não sofro de ansiedade ou depressão  
Sofro moderadamente de ansiedade/depressão  
Sofro extremamente de ansiedade/depressão  
 *Com base em [115] 
Nota importante: Só podem realizar os testes pretendidos quem obtiver pontuação nula neste 
questionário. 
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1.De acordo com os tópicos abaixo descritos, selecione para cada pergunta, a opção com qual se 
identifica. 
Questões Respostas Pontuação 
Qual é a cor da sua pele quando 
não está bronzeada? 
Avermelhada 
Clara/Pálida 
Castanho claro 
Castanho escuro 
1 
2 
3 
4 
Tem sardas? Sim, muitas 
Sim, algumas 
Sim, poucos 
Não 
1 
2 
3 
4 
Como é que a sua pele reage à 
exposição solar? 
Muito sensível, susceptível a irritação 
Sensível, por vezes com irritação 
Geralmente sensível, raramente irritação 
Insensível, nenhuma irritação 
1 
2 
3 
4 
Quanto tempo é que se pode expor 
ao sol, num céu sem nuvens, ao 
meio dia, sem ficar com 
queimaduras? 
Menos de 15 minutos 
Entre 15 a 20 minutos 
Entre 25 e 40 minutos 
Mais de 40 minutos 
1 
2 
3 
4 
Como é que a sua pele reage à 
longa exposição solar? 
Sempre com queimaduras solares 
Principalmente com queimaduras solares 
Muitas vezes com queimaduras solares 
Raramente ou nunca com queimaduras 
solares 
1 
2 
3 
4 
Que tipo de queimaduras costuma 
desenvolver sempre que se expõe 
ao sol durante muito tempo? 
Vermelhão forte, bolhas dolorosas, 
descamação da pele 
Vermelho claro, seguido por descamação 
Avermelhamento, seguido por vezes por 
descamação 
Quase nunca vermelhão e descamação 
1 
2 
3 
4 
Alguma vez experimentou efeito 
de bronzeamento após banhos de 
sol durante um período de tempo 
prolongado? 
Nunca 
Quase nunca 
Frequentemente 
Quase sempre 
1 
2 
3 
4 
Como funciona o seu bronzeado 
após banhos de sol repetidos? 
Nunca ou quase nunca 
Bronze mínimo 
Progressivo, bronze claro 
Rápido, bronze profundo 
1 
2 
3 
4 
Como descreve a sua cor natural 
de cabelo? 
Vermelho até castanho avermelhado 
Castanho claro até loiro 
Loiro escuro até castanho 
Castanho escuro até preto 
1 
2 
3 
4 
Como descreve a sua cor de olhos? Azul claro, cinza, ou verde claro 
Azul, cinza ou verde 
Castanho claro ou cinza escuro 
Castanho escuro 
1 
2 
3 
4 
Total  
 
2. Tem parentes com melanomas? 
a. Sim  
b. Não 
c. Não sei  
 
2.1.Se respondeu sim à questão anterior, indique qual o grau de parentesco. 
a. Pai/mãe 
b. Tio/Tia 
c. Irmão/Irmã 
d. Filho/Filha 
e. Outro 
79 
 
*Com base em [116, 117]. 
Nota importante: A pontuação obtida neste questionário diz respeito à sensibilidade solar da pele. 
Tendo um mínimo de 10, representando alta sensibilidade solar, enquanto que um máximo de 40, 
representa baixa sensibilidade solar 
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APPENDIXE V: ANS results of p-value and ranking values to right side 
of each phase 
 
Moment I to II Moment II to III Moment I to III 
U W Z p U W Z p U W Z p 
Fr
o
n
ta
l R1 66.0 121.0 -0.2 0.80 44.0 99.0 -1.5 0.10 69.5 124.5 0.0 1.00 
R2 63.5 118.5 -0.4 0.70 47.5 102.5 -1.3 0.20 63.0 118.0 -0.4 0.70 
R3 56.5 111.5 -0.8 0.40 59.5 114.5 -0.6 0.50 65.5 120.5 -0.3 0.80 
P
ro
fi
le
 R1 64.0 119.0 -0.4 0.70 42.0 97.0 -1.6 0.10 70.0 125.0 0.0 1.00 
R2 62.0 117.0 -0.5 0.60 52.0 107.0 -1.1 0.30 70.0 125.0 0.0 1.00 
R3 61.0 116.0 -0.5 0.60 56.5 111.5 -0.8 0.40 66.5 171.5 -0.2 0.80 
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APPENDICE VI: ANS mean temperatures to left side of each phase and 
results of p-value and ranking values 
 
ROIs Phase 1st Moment 2nd Moment 3rd Moment 
F
ro
n
ta
l 
R1 
1 34.64 ± 0.43 32.76 ± 0.84 34.21 ± 0.73 
2 34.54 ± 0.71 32.24 ± 0.67 34.25 ± 0.77 
R2 
1 33.97 ± 0.69 32.46 ± 0.66 33.72 ± 0.82 
2 33.90 ± 0.90 32.11 ± 1.04 33.78 ± 0.91 
R3 
1 33.72 ± 0.69 31.95 ± 0.70 33.18 ± 0.99 
P
ro
fi
le
 
2 33.10 ± 0.74 31.56 ± 1.07 33.12 ± 0.84 
R1 
1 34.28 ± 0.44 32.54 ± 0.79 33.73 ± 0.75 
2 33.98 ± 0.62 32.15 ± 0.69 33.78 ± 0.72 
R2 
1 33.61 ± 0.79 31.90 ± 0.85 32.87 ± 0.84 
2 33.26 ± 0.98 31.61 ± 1.06 32.87 ± 1.02 
R3 
1 33.79 ± 0.74 32.12 ± 0.64 32.99 ± 0.86 
2 33.51 ± 0.74 31.87 ± 0.97 33.09 ± 0.74 
 
 
 
Moment I to II Moment II to III Moment I to III 
U W Z p U W Z p U W Z p 
F
ro
n
ta
l R1 66 121 -0.24 0.81 39 94 -1.79 0.07 67 172 -0.18 0.86 
R2 69 124 -0.06 0.95 56 111 -0.82 0.41 66 171 -0.20 0.84 
R3 36 91 -1.96 0.05 55 110 -0.85 0.4 60 115 -0.56 0.58 
P
ro
fi
le
 R1 50 105 -1.18 0.24 50 105 -1.14 0.25 70 125 0.00 1.00 
R2 53 108 -1.00 0.32 62 117 -0.47 0.64 65 170 -0.29 0.77 
R3 55 110 -0.88 0.38 60 115 -0.56 0.58 68 173 -0.12 0.91 
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Appendix VII: MS mean temperatures to right side of each gender and 
results of p-value and U,W an Z values 
 
ROIs Gender 1st Moment 2nd Moment 3rd Moment 
F
ro
n
ta
l 
R1 
F 32.06 ± 1.56 30.33 ± 1.44 31.98 ± 1.86 
M 32.41 ± 1.16 31.51 ± 1.28 33.43 ± 1.41 
R2 
F 33.88 ± 0.91 32.38 ± 0.93 33.75 ± 1.02 
M 33.98 ± 0.73 32.75 ± 0.76 34.26 ± 0.80 
R3 
F 33.99 ± 0.81 32.05 ± 1.00 33.66 ± 0.97 
M 33.96 ± 0.78 32.47 ± 0.71 33.98 ± 0.71 
R4 
F 34.56 ± 0.53 32.51 ± 0.81 34.11 ± 0.78 
M 34.68 ± 0.43 33.03 ± 0.41 34.49 ± 0.35 
R5 
F 34.28 ± 0.46 32.94 ± 0.59 33.95 ± 0.58 
M 34.09 ± 0.44 33.06 ± 0.39 33.97 ± 0.24 
R6 
F 33.18± 1.06 31.08 ± 1.07 32.46 ± 1.18 
M 33.81 ±0.62 32.17 ± 0.53 33.78 ± 0.58 
R7 
F 33.59 ± 0.95 31.78 ± 1.13 33.07 ± 1.16 
M 34.01 ± 0.88 32.63 ± 0.69 33.94 ± 0.66 
R8 
F 34.60 ± 0.50 33.19 ± 0.79 34.36 ± 0.64 
M 34.78 ± 0.31 33.53 ± 0.45 34.74 ± 0.41 
R9 
F 32.93 ± 0.68 31.26 ± 0.72 32.32 ± 0.73 
M 33.67 ± 0.45 32.31 ± 0.30 33.39 ± 0.49 
P
ro
fi
le
 
R1 
F 30.90 ± 2.25 29.72 ± 2.07 31.04 ± 2.59 
M 31.73 ± 1.77 31.29 ± 1.90 32.96 ± 2.13 
R2 
F 33.47 ± 1.15 32.32 ± 0.99 33.59 ± 0.97 
M 33.13 ± 0.96 32.44 ± 1.11 33.58 ± 1.10 
R3 
F 33.71 ± 0.79 31.85 ± 0.94 33.45 ± 0.90 
M 33.96 ± 0.47 32.50± 0.64 33.96 ± 0.57 
R4 
F 34.26 ± 0.66 32.60 ± 0.81 33.86 ± 0.77 
M 34.38 ± 0.53 33.03 ± 0.45 34.23 ± 0.34 
R5 
F 33.98 ± 0.50 32.75 ± 0.65 33.71 ± 0.64 
M 33.91 ± 0.57 33.05 ± 0.40 33.91 ± 0.29 
R6 
F 32.60 ± 1.12 30.77 ± 1.14 32.05 ± 1.19 
M 33.76 ± 0.61 32.30 ± 0.46 33.62 ± 0.52 
R7 
F 33.39 ± 0.89 31.6 ± 0.99 32.84 ± 1.07 
M 34.28 ± 0.62 32.99 ± 0.58 34.07 ± 0.60 
R8 
F 33.37± 0.88 31.70 ± 0.84 32.73 ± 0.84 
M 34.19 ± 0.55 32.91 ± 0.41 33.86 ± 0.50 
R9 
F 34.45 ± 0.82 32.7 ± 0.94 33.68 ± 0.77 
M 34.45 ± 0.57 33.44 ± 0.66 34.31 ± 0.48 
83 
R10 
F 33.16 ± 0.99 31.40 ± 0.92 32.46 ± 0.94 
M 34.16 ± 0.59 32.70 ± 0.50 33.85 ± 0.63 
 
 
 
ROI's 
Moment I to II Moment II to III Moment I to III 
U W Z p U W Z p U W Z p 
F
ro
n
ta
l 
R1 166 466 -0.70 0.48 100 400 -2.54 0.01 94 394 -2.69 0.01 
R2 187 487 -0.14 0.89 158 458 -0.94 0.35 132 432 -1.65 0.10 
R3 186 322 -0.17 0.87 151 451 -1.12 0.26 153 453 -1.08 0.28 
R4 173 473 -0.51 0.61 107 407 -2.35 0.02 143 443 -1.36 0.18 
R5 147 283 -1.23 0.22 172 472 -0.55 0.58 176 312 -0.43 0.67 
R6 130 430 -1.70 0.09 70 370 -3.37 0.00 55 355 -3.79 0.00 
R7 140 440 -1.44 0.15 115 415 -2.12 0.03 98 98 -2.60 0.01 
R8 155 455 -1.03 0.30 137 437 -1.51 0.13 126 426 -1.83 0.07 
R9 72 372 -3.32 0.00 39 339 -4.23 0.00 35 335 -4.34 0.00 
P
ro
fi
le
 
R1 150 450 -1.15 0.25 105 405 -2.39 0.02 101 401 -2.51 0.01 
R2 143 279 -1.34 0.18 178 478 -0.37 0.71 190 326 -0.06 0.96 
R3 162 462 -0.82 0.41 109 409 -2.29 0.02 135 435 -1.58 0.12 
R4 180 480 -0.32 0.75 139 439 -1.47 0.14 152 452 -1.11 0.27 
R5 186 322 -0.15 0.88 150 450 -1.16 0.25 173 473 -0.51 0.61 
R6 78 378 -3.14 0.00 31 331 -4.44 0.00 39 339 -4.21 0.00 
R7 82 382 -3.04 0.00 33 333 -4.4 0.00 61 361 -3.62 0.00 
R8 86 386 -2.92 0.00 37 337 -4.29 0.00 48 348 -3.98 0.00 
R9 180 316 -0.33 0.74 100 400 -2.53 0.01 92 392 -2.75 0.01 
R10 79 379 -3.11 0.00 34 334 -4.37 0.00 35 335 -4.33 0.00 
 
 
  
84 
Appendix VIII: MS mean temperatures to left side of each gender and 
results of p-value and U,W an Z values 
 
ROIs Gender 1st Moment 2nd Moment 3rd Moment 
F
ro
n
ta
l 
R1 
F 32.15 ± 1.57 30.59 ± 1.51 32.16 ± 1.90 
M 32.54 ± 1.25 31.66 ± 1.35 33.36 ± 1.48 
R2 
F 33.98 ± 0.64 32.54 ± 0.74 33.87 ± 0.82 
M 33.84 ± 0.75 32.66 ± 0.79 34.01 ± 0.64 
R3 
F 33.95 ± 0.71 32.08 ± 0.84 33.50 ± 0.96 
M 33.87 ± 0.86 32.44 ± 0.70 33.86 ± 0.69 
R4 
F 34.60 ± 0.54 32.60 ± 0.81 34.10 ± 0.83 
M 34.61 ± 0.41 32.93 ± 0.34 34.39 ± 0.31 
R5 
F 34.30 ± 0.51 32.95 ± 0.63 33.95 ± 0.59 
M 34.06 ± 0.38 33.00 ± 0.37 33.93 ± 0.23 
R6 
F 33.18 ± 1.08 31.18 ± 1.05 32.74 ± 1.18 
M 33.79 ± 0.67 32.17 ± 0.63 33.75 ± 0.70 
R7 
F 33.64 ± 0.86 31.95 ± 0.83 33.17 ± 1.00 
M 33.88 ± 0.78 32.61 ± 0.57 33.78 ± 0.65 
R8 
F 34.47 ± 0.66 33.08 ± 0.76 34.13 ± 0.61 
M 34.65 ± 0.46 33.36 ± 0.40 34.54 ± 0.38 
R9 
F 32.93 ± 0.81 31.30 ± 0.91 32.29 ± 0.86 
M 33.56 ± 0.47 32.31 ± 0.77 33.35 ± 0.42 
P
ro
fi
le
 
R1 
F 30.93 ± 2.32 29.80 ± 2.17 31.03 ± 2.96 
M 31.69 ± 1.78 31.29 ± 1.99 32.94 ± 2.22 
R2 
F 33.42 ± 0.91 32.32 ± 0.91 33.57 ± 1.04 
M 32.92 ± 1.06 32.36 ± 1.18 33.59 ± 0.89 
R3 
F 33.61 ± 0.70 31.99 ± 0.90 33.32 ± 0.93 
M 33.92 ± 0.62 32.58 ± 0.77 33.88 ± 0.60 
R4 
F 34.39 ± 0.55 32.71 ± 0.72 33.95 ± 0.65 
M 34.36 ± 0.59 32.91 ± 0.45 34.15 ± 0.45 
R5 
F 34.00 ± 0.57 32.76 ± 0.74 33.68 ± 0.85 
M 33.93 ± 0.45 32.94 ± 0.45 33.21 ± 2.69 
R6 
F 32.75 ± 1.10 31.07 ± 1.13 32.22 ± 1.22 
M 33.76 ± 0.68 32.27 ± 0.65 33.62 ± 0.70 
R7 
F 33.60 ± 0.78 32.00 ± 0.79 33.14 ± 0.93 
M 34.27 ± 0.62 33.03 ± 0.48 34.09 ± 0.52 
R8 
F 33.38 ± 0.89 31.85 ± 0.81 32.72 ± 0.90 
M 34.24 ± 0.58 32.92 ± 0.47 33.93 ± 0.50 
R9 
F 34.28 ± 0.77 32.73 ± 0.85 33.62 ± 0.61 
M 34.64 ± 0.44 33.38 ± 0.78 34.35 ± 0.57 
R10 
F 33.02 ± 0.99 31.42 ± 0.96 32.35 ± 0.92 
M 34.18 ± 0.65 32.84 ± 0.61 33.96 ± 0.74 
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ROI's 
Moment I to II Moment II to III Moment I to III 
U W Z p U W Z p U W Z p 
F
ro
n
ta
l 
R1 159 459 -0.89 0.36 112 412 -2.21 0.02 121 421 -1.96 0.05 
R2 172 308 -0.55 0.58 189 489 -0.06 0.94 178 478 -0.37 0.70 
R3 182 318 -0.26 0.79 148 448 -1.20 0.22 144 444 -1.31 0.19 
R4 190 326 -0.05 0.95 134 434 -1.60 0.10 164 464 -0.77 0.43 
R5 121 257 -1.96 0.04 190 490 -0.05 0.95 189 325 -0.08 0.93 
R6 139 439 -1.45 0.14 89 389 -2.84 0.04 86 386 -2.93 0.03 
R7 166 466 -0.71 0.47 99 399 -2.55 0.01 111 411 -2.22 0.02 
R8 157 457 -0.96 0.33 146 446 -1.25 0.20 117 417 -2.06 0.03 
R9 111 411 -2.24 0.02 75 375 -3.21 0.01 52 352 -3.87 0.00 
P
ro
fi
le
 
R1 147 447 -1.24 0.21 117 417 -2.07 0.03 118 418 -2.04 0.04 
R2 135 271 -1.56 0.11 177 313 -0.41 0.67 183 319 -0.23 0.81 
R3 144 444 -1.31 0.18 121 421 -1.94 0.05 118 418 -2.04 0.04 
R4 186 322 -0.16 0.86 151 451 -1.12 0.26 160 460 -0.88 0.37 
R5 175 311 -0.45 0.64 177 477 -0.40 0.68 179 315 -0.36 0.71 
R6 98 398 -2.59 0.00 68 368 -3.41 0.01 51 351 -3.88 0.00 
R7 102 402 -2.47 0.01 48 348 -3.98 0.00 65 365 -3.50 0.00 
R8 83 383 -2.99 0.00 52 352 -3.87 0.00 47 347 -4.00 0.00 
R9 142 442 -1.38 0.16 108 408 -2.30 0.02 70 370 -3.36 0.01 
R10 64 364 -3.52 0.00 37 337 -4.27 0.00 29 329 -4.50 0.00 
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Appendix IX: MS thermal symmetry of each gender and results of p-
value, U,W and Z values 
 
 
ROIs Gender 1st Moment 2nd Moment 3rd Moment 
F
ro
n
ta
l 
R1 
F 0.26 ± 0.02 0.32 ± 0.31 0.22 ± 0.16 
M 0.34 ± 0.52 0.39 ± 0.48 0.22 ± 0.18 
R2 
F 0.41 ± 0.37 0.52 ± 0.40 0.45 ± 0.44 
M 0.34 ± 0.25 0.48 ± 0.48 0.40 ± 0.30 
R3 
F 0.30 ± 0.20 0.38 ± 0.20 0.39 ± 0.33 
M 0.19 ± 0.15 0.19 ± 0.16 0.21 ± 0.17 
R4 
F 0.15 ± 0.14 0.26 ± 0.26 0.20 ± 0.15 
M 0.14 ± 0.14 0.24 ± 0.21 0.19 ± 0.16 
R5 
F 0.15 ± 0.08 0.16 ± 0.12 0.14 ± 0.11 
M 0.16 ± 0.15 0.14 ± 0.14 0.09 ± 0.10 
R6 
F 0.47 ± 0.63 0.30 ± 0.24 0.44 ± 0.45 
M 0.25 ± 0.18 0.29 ± 0.22 0.28 ± 0.19 
R7 
F 0.37 ± 0.41 0.54 ± 0.31 0.43 ± 0.52 
M 0.33 ± 0.21 0.33 ± 0.16 0.22 ± 0.18 
R8 
F 0.30 ± 0.41 0.36 ± 0.24 0.35 ± 0.39 
M 0.25 ± 0.23 0.28 ± 0.17 0.27 ± 0.23 
R9 
F 0.35 ± 0.29 0.41 ± 0.32 0.35 ± 0.23 
M 0.34 ± 0.26 0.38 ± 0.52 0.40 ± 0.31 
P
ro
fi
le
 
R1 
F 0.83 ± 0.68 1.03 ± 0.76 0.90 ± 0.59 
M 0.87 ± 0.56 0.51 ± 0.44 0.44 ± 0.40 
R2 
F 0.55 ± 0.40 0.56 ± 0.44 0.44 ± 0.38 
M 0.39 ± 0.48 0.50 ± 0.39 0.35 ± 0.27 
R3 
F 0.40 ± 0.29 0.46 ± 0.41 0.34 ± 0.30 
M 0.22 ± 0.21 0.39 ± 0.30 0.20 ± 0.24 
R4 
F 0.22 ± 0.27 0.40 ± 0.26 0.23 ± 0.28 
M 0.26 ± 0.15 0.38 ± 0.34 0.22 ± 0.21 
R5 
F 0.20 ± 0.15 0.33 ± 0.43 0.35 ± 0.65 
M 0.32 ± 0.21 0.21 ± 0.20 0.86 ± 2.58 
R6 
F 0.31 ± 0.23 0.43 ± 0.39 0.34 ± 0.34 
M 0.28 ± 0.21 0.37 ± 0.28 0.35 ± 0.27 
R7 
F 0.31 ± 0.26 0.53 ± 0.40 0.50 ± 0.38 
M 0.18 ± 0.14 0.26 ± 0.25 0.24 ± 0.16 
R8 
F 0.28 ± 0.24 0.30 ± 0.26 0.22 ± 0.18 
M 0.31 ± 0.21 0.15 ± 0.12 0.20 ± 0.20 
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R9 
F 0.44 ± 0.45 0.41 ± 0.35 0.35 ± 0.25 
M 0.38 ± 0.32 0.31 ± 0.19 0.28 ± 0.29 
R10 
F 0.39 ± 0.23 0.27 ± 0.23 0.31 ± 0.24 
M 0.34 ± 0.17 0.33 ± 0.23 0.31 ± 0.28 
      
 
 
ROI's 
Moment I to II Moment II to III Moment I to III 
U W Z p U W Z p U W Z p 
F
ro
n
ta
l 
R1 175 311 -0.48 0.63 181 481 -0.29 0.76 186 322 -0.15 0.87 
R2 181 317 -0.30 0.75 174 310 -0.50 0.61 185 485 -0.19 0.84 
R3 128 264 -1.79 0.07 93 229 -2.76 0.00 113 249 -2.20 0.02 
R4 189 325 -0.07 0.94 190 326 -0.05 0.95 176 312 -0.43 0.66 
R5 175 311 -0.47 0.63 168 304 -0.66 0.50 132 268 -1.74 0.08 
R6 141 277 -1.42 0.13 190 326 -0.04 0.96 156 292 -1.00 0.31 
R7 178 478 -0.37 0.76 104 240 -2.45 0.01 158 294 -0.95 0.33 
R8 192 328 0.00 1 158 294 -0.93 0.34 189 325 -0.07 0.94 
R9 190 490 -0.04 0.96 146 282 -1.26 0.20 164 464 -0.76 0.44 
P
ro
fi
le
 
R1 171 471 -0.58 0.56 110 246 -2.25 0.02 105 241 -2.40 0.01 
R2 141 277 -1.41 0.15 173 309 -0.51 0.60 171 307 -0.56 0.56 
R3 119 255 -2.04 0.04 178 314 -0.39 0.69 136 272 -1.57 0.11 
R4 132 432 -1.69 0.09 172 308 -0.54 0.58 178 478 -0.38 0.70 
R5 124 424 -1.91 0.05 156 292 -1.01 0.31 191 327 -0.02 0.97 
R6 184 320 -0.22 0.82 182 318 -0.27 0.78 176 476 -0.44 0.65 
R7 138 274 -1.51 0.13 111 247 -2.24 0.02 118 254 -2.04 0.04 
R8 166 466 -0.72 0.47 118 254 -2.09 0.03 168 304 -0.68 0.49 
R9 188 324 -0.09 0.92 167 303 -0.69 0.48 146 282 -1.27 0.20 
R10 183 319 -0.23 0.81 155 455 -1.02 0.30 185 321 -0.18 0.85 
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Appendix X: MS mean temperatures of right side of each phase and 
results of p-value, U,W and Z values 
 
 ROIs Phase  1st Moment 2nd Moment 3rd Moment 
Fr
o
n
ta
l 
R1 1 32,19 ± 1,31 30,59 ± 1,26 32,29 ± 1,81 
2 31,88 ± 1,92 29,96 ± 1,65 31,55 ± 1,94 
R2 1 34,16 ± 0,70 32,54 ± 0,78 33,79 ± 1,06 
2 33,75 ± 0,92 32,17 ± 1,12 33,69 ± 1,01 
R3 1 34,16 ± 0,70 32,23 ± 1,01 33,68 ± 1,05 
2 33,75 ± 0,92 31,79 ± 0,98 33,64 ± 0,90 
R4 1 34,59 ± 0,49 32,73 ± 0,86 34,03 ± 0,86 
2 34,52 ± 0,60 32,20 ± 0,64 34,22 ± 0,69 
R5 1 34,31 ± 0,36 33,08 ± 0,57 33,90 ± 0,58 
2 34,22 ± 0,58 32,74 ± 0,58 34,01 ± 0,60 
R6 1 33,36 ± 0,96 31,21 ± 1.00 32,45 ± 1,16 
2 32,94 ± 1,20 30,88 ± 1,18 32,48 ± 1,27 
R7 1 33,69 ± 0,92 32.00 ± 0,88 33,11 ± 1,05 
2 33,44 ± 1,01 31,47 ± 1,41 33,01 ± 1,34 
R8 1 34,62 ± 0,48 33,41 ± 0,71 34,31 ± 0,73 
2 34,56 ± 0,55 32,88 ± 0,84 34,42 ± 0,53 
R9 1 33,01 ± 0,62 31,39 ± 0,67 32,28 ± 0,71 
2 32,81 ± 0,78 31,09 ± 0,80 32,38 ± 0,79 
P
ro
fi
le
 
R1 1 31.00 ± 2,21 29,94 ± 2,03 31,39 ± 2,66 
2 30,76 ± 2,42 29,41 ± 2,20 30,55 ± 2,53 
R2 1 33,52 ± 1,17 32,43 ± 1,01 33,66 ± 1,11 
2 33,39 ± 1,18 32,17 ± 1.00 33,49 ± 0,78 
R3 1 33,89 ± 0,67 32,01 ± 0,95 33,49 ± 0,87 
2 33,47 ± 0,90 31,62 ± 0,91 33,41 ± 0,98 
R4 1 34,31 ± 0,62 32,79 ± 0,76 33,81 ± 0,87 
2 34,18 ± 0,74 32,33 ± 0,83 33,93 ± 0,64 
R5 1 34,01 ± 0,4 32,86 ± 0,57 33,69 ± 0,58 
2 33,92 ± 0,65 32,59 ± 0,75 33,75 ± 0,74 
R6 1  32,74 ± 1.00 30,96 ± 0,95 32,02 ± 1,12 
2 32,40 ± 1,30 30,50 ± 1,37 32,1 ± 1,35 
R7 1 33,51 ± 0,86 31,75 ± 0,81 32,87 ± 1,09 
2 33,23 ± 0,96 31,39 ± 1,21 32,79 ± 1,1 
R8 1 33,47 ± 0,85 31,86 ± 0,74 32,67 ± 0,82 
2 33,23 ± 0,96 31,47 ± 0,95 32,8 ± 0,92 
R9 1 34,53 ± 0,93 32,80 ± 0,91 33,67 ± 0,85 
89 
2 34,33 ± 0,93 32,56 ± 1,01 33,68 ± 0,67 
R10 1 33,28 ± 1,03 31,60± 0,80 32,39 ± 0,96 
2 32,99 ± 0,95 31,20 ± 1,11 32,56 ± 0,94 
 
 
ROI's 
Moment I to II Moment II to III Moment I to III 
U W Z p U W Z p U W Z p 
F
ro
n
ta
l 
R1 59 114 -0.65 0.52 57 112 -0.79 0.43 55 110 -0.91 0.36 
R2 57 112 -0.79 0.43 59 114 -0.68 0.50 66 121 -0.24 0.82 
R3 49 104 -1.27 0.21 50 105 -1.20 0.23 68 123 -0.15 0.88 
R4 64 119 -0.35 0.72 41 95.5 -1.73 0.08 62 167 -0.47 0.64 
R5 51 106 -1.12 0.26 44 99 -1.53 0.13 65 170 -0.32 0.75 
R6 58 113 -0.70 0.48 57 112 -0.76 0.45 68 173 -0.12 0.91 
R7 59 114 -0.68 0.50 58 113 -0.70 0.48 68 123 -0.12 0.91 
R8 64 119 -0.35 0.72 33 88 -2.18 0.03 67 172 -0.18 0.86 
R9 62 117 -0.50 0.62 53 108 -1.03 0.31 68 173 -0.12 0.91 
P
ro
fi
le
 
R1 65 120 -0.32 0.75 61 116 -0.53 0.60 54 109 -0.97 0.33 
R2 61 116 -0.56 0.58 65 120 -0.32 0.75 55 110 -0.88 0.38 
R3 50 105 -1.18 0.24 54 109 -0.97 0.33 62 117 -0.47 0.64 
R4 63 118 -0.41 0.68 45 100 -1.47 0.14 67 172 -0.21 0.84 
R5 60 115 -0.59 0.56 57 112 -0.76 0.45 67 172 -0.21 0.84 
R6 60 115 -0.62 0.54 56 111 -0.85 0.40 67 172 -0.18 0.86 
R7 58 113 -0.71 0.48 59 114 -0.68 0.50 70 125 -0.03 0.98 
R8 60 115 -0.59 0.56 48 103 -1.29 0.20 64 169 -0.35 0.73 
R9 53 108 -1.03 0.30 58 113 -0.73 0.46 67 122 -0.21 0.84 
R10 61 116 -0.56 0.58 54 109 -0.97 0.33 66 171 -0.26 0.79 
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Appendix XI: MS mean temperatures of left side of each phase and 
results of p-value, U,W and Z values 
 
ROIs Phase 1st Moment 2nd Moment 3rd Moment 
F
ro
n
ta
l 
R1 
1 32.26 ± 1.32 30.83 ± 1.33 32.41 ± 1.9 
2 31.99 ± 1.94 30.26 ± 1.76 31.81 ± 1.93 
R2 
1 34.11 ± 0.55 32.72 ± 0.58 33.83 ± 0.87 
2 33.78 ± 0.74 32.29 ± 0.89 33.92 ± 0.79 
R3 
1 34.12 ± 0.62 32.24 ± 0.67 33.56 ± 0.90 
2 33.72 ± 0.80 31.86 ± 1.03 33.4 ± 1.08 
R4 
1 34.12 ± 0.62 32.75 ± 0.83 34.04 ± 0.81 
2 33.72 ± 0.80 32.40 ± 0.77 34.17 ± 0.90 
R5 
1 34.30 ± 0.36 33.07 ± 0.61 33.89 ± 0.58 
2 34.31 ± 0.69 32.78 ± 0.65 34.04 ± 0.63 
R6 
1 33.32 ± 0.81 31.30 ± 0.73 32.54 ± 1.10 
2 32.97 ± 1.39 31.02 ± 1.41 33.03 ± 1.30 
R7 
1 33.64 ± 0.95 32.06 ± 0.63 33.07 ± 1.00 
2 33.64 ± 0.76 31.80 ± 1.07 33.31 ± 1.03 
R8 
1 34.41 ± 0.75 33.24 ± 0.61 34.06 ± 0.58 
2 34.56 ± 0.53 32.87 ± 0.91 34.22 ± 0.67 
R9 
1 33.04 ± 0.66 31.39 ± 0.58 32.29 ± 0.72 
2 32.77 ± 1.01 31.19 ± 1.26 32.29 ± 1.07 
P
ro
fi
le
 
R1 
1 30.93 ± 2.14 29.94 ± 2.10 31.39 ± 2.66 
2 30.93 ± 2.68 29.60 ± 2.37 30.55 ± 2.53 
R2 
1 33.52 ± 0.99 32.51 ± 0.87 33.66 ± 1.11 
2 33.27 ± 0.81 32.05 ± 0.94 33.49 ± 0.78 
R3 
1 33.84 ± 0.57 32.19 ± 0.73 33.49 ± 0.87 
2 33.29 ± 0.76 31.70 ± 1.06 33.41 ± 0.98 
R4 
1 34.51 ± 0.45 32.74 ± 0.77 33.81 ± 0.87 
2 34.22 ± 0.66 32.67 ± 0.69 33.93 ± 0.64 
R5 
1 34.11 ± 0.42 32.89 ± 0.63 33.69 ± 0.58 
2 33.86 ± 0.74 32.59 ± 0.87 33.75 ± 0.74 
R6 
1 32.95 ± 0.9 31.14 ± 0.82 32.02 ± 1.12 
2 32.46 ± 1.33 30.97 ± 1.51 32.10 ± 1.35 
R7 
1 33.76 ± 0.75 32.05 ± 0.64 32.87 ± 1.09 
2 33.36 ± 0.79 31.93 ± 1.00 32.79 ± 1.10 
R8 
1 33.49 ± 0.82 31.96 ± 0.68 32.67 ± 0.82 
2 33.22 ± 1.00 31.69 ± 0.98 32.80 ± 0.92 
R9 1 34.33 ± 0.89 32.89 ± 0.81 33.67 ± 0.85 
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2 34.20 ± 0.58 32.49 ± 0.88 33.68 ± 0.67 
R10 
1 33.20 ± 1.05 31.62 ± 0.90 32.39 ± 0.96 
2 32.77 ± 0.89 31.14 ± 1.02 32.56 ± 0.94 
 
 
 
ROI's 
Moment I to II Moment II to III Moment I to III 
U W Z p U W Z p U W Z p 
F
ro
n
ta
l 
R1 62 117 -0.47 0.64 57 112 -0.76 0.45 57 112 -0.76 0.45 
R2 48 103 -1.29 0.20 49 104 -1.23 0.22 67 172 -0.18 0.86 
R3 51 106 0.84 0.26 50 105 -1.17 0.24 60 115 -0.62 0.54 
R4 63 118 -0.41 0.68 41 96 -1.73 0.08 63 168 -0.44 0.66 
R5 69 124 -0.06 0.95 51 106 -1.12 0.26 64 169 -0.35 0.73 
R6 63 118 -0.44 0.66 67 122 -0.21 0.84 56 161 -0.85 0.40 
R7 64 119 -0.35 0.73 51 106 -1.11 0.27 66 171 -0.24 0.81 
R8 66 171 -0.24 0.81 49 104 -1.23 0.22 57 162 -0.79 0.43 
R9 63 118 -0.44 0.66 59 114 -0.65 0.52 70 125 0.00 1.00 
P
ro
fi
le
 
R1 70 125 -0.03 0.98 65 120 -0.32 0.75 63 118 -0.44 0.66 
R2 57 112 -0.76 0.45 46 101 -1.41 0.16 56 111 -0.82 0.41 
R3 41 96 -1.70 0.09 51 106 -1.11 0.27 61 116 -0.53 0.60 
R4 52 107 -1.06 0.29 67 122 -0.21 0.84 60 165 -0.62 0.54 
R5 54 109 -0.94 0.35 57 112 -0.79 0.43 50 155 -1.20 0.23 
R6 57 112 -0.76 0.45 67 172 -0.18 0.86 61 166 -0.53 0.60 
R7 48 103 -1.32 0.19 63 118 -0.44 0.66 67 122 -0.18 0.86 
R8 58 113 -0.70 0.48 60 115 -0.59 0.56 63 168 -0.41 0.68 
R9 57 112 -0.79 0.43 53 108 -1.03 0.31 54 159 -0.94 0.35 
R10 52 107 -1.09 0.28 52 107 -1.09 0.28 69 174 -0.06 0.95 
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Appendix XII: MS thermal symmetry of each phase and results of p-
value, U,W and Z values 
 
 
 
ROIs Phase 1st Moment 2nd Moment 3rd Moment 
F
ro
n
ta
l 
R1 
1 0.32 ± 0.22 0.31 ± 0.27 0.19 ± 0.14 
2 0.17 ± 0.14 0.32 ± 0.38 0.26 ± 0.19 
R2 
1 0.42 ± 0.36 0.50 ± 0.43 0.42 ± 0.47 
2 0.39 ± 0.40 0.54 ± 0.36 0.49 ± 0.41 
R3 
1 0.34 ± 0.22 0.36 ± 0.24 0.31 ± 0.21 
2 0.25 ± 0.17 0.39 ± 0.15 0.50 ± 0.45 
R4 
1 0.15 ± 0.17 0.25 ± 0.19 0.19 ± 0.12 
2 0.15 ± 0.12 0.28 ± 0.34 0.23 ± 0.18 
R5 
1 0.14 ± 0.09 0.19 ± 0.13 0.15 ± 0.11 
2 0.17 ± 0.07 0.12 ± 0.09 0.13 ± 0.12 
R6 
1 0.56 ± 0.81 0.29 ± 0.21 0.29 ± 0.23 
2 0.33 ± 0.19 0.32 ± 0.29 0.65 ± 0.59 
R7 
1 0.29 ± 0.30 0.45 ± 0.20 0.31 ± 0.43 
2 0.48 ± 0.52 0.67 ± 0.40 0.58 ± 0.62 
R8 
1 0.37 ± 0.46 0.36 ± 0.20 0.29 ± 0.24 
2 0.20 ± 0.33 0.35 ± 0.30 0.44 ± 0.53 
R9 
1 0.27 ± 0.23 0.27 ± 0.17 0.21 ± 0.24 
2 0.46 ± 0.33 0.60 ± 0.38 0.55 ± 0.37 
P
ro
fi
le
 
R1 
1 0.77 ± 0.69 0.86 ± 0.83 0.73 ± 0.55 
2 0.91 ± 0.69 1.27 ± 0.62 1.14 ± 0.60 
R2 
1 0.57 ± 0.42 0.57 ± 0.54 0.44 ± 0.42 
2 0.52 ± 0.39 0.54 ± 0.26 0.45 ± 0.32 
R3 
1 0.31 ± 0.28 0.35 ± 0.38 0.25 ± 0.27 
2 0.52 ± 0.28 0.62 ± 0.41 0.47 ± 0.32 
R4 
1 0.26 ± 0.33 0.36 ± 0.23 0.28 ± 0.33 
2 0.16 ± 0.14 0.46 ± 0.29 0.16 ± 0.16 
R5 
1 0.22 ± 0.19 0.24 ± 0.22 0.39 ± 0.85 
2 0.18 ± 0.08 0.46 ± 0.61 0.29 ± 0.18 
R6 
1 0.36 ± 0.26 0.39 ± 0.26 0.29 ± 0.39 
2 0.24 ± 0.19 0.49 ± 0.53 0.41 ± 0.26 
R7 
1 0.31 ± 0.27 0.43 ± 0.30 0.49 ± 0.41 
2 0.31 ± 0.25 0.66 ± 0.49 0.51 ± 0.35 
R8 1 0.21 ± 0.20 0.24 ± 0.19 0.19 ± 0.19 
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2 0.37 ± 0.26 0.40 ± 0.32 0.26 ± 0.16 
R9 
1 0.51 ± 0.55 0.41 ± 0.31 0.34 ± 0.27 
2 0.33 ± 0.24 0.41 ± 0.41 0.36 ± 0.23 
R10 
1 0.35 ± 0.22 0.29 ± 0.19 0.28 ± 0.28 
2 0.44 ± 0.24 0.24 ± 0.29 0.36 ± 0.18 
 
 
 ROI's Moment I to II Moment II to III Moment I to III 
U W Z p U W Z p U W Z p 
F
ro
n
ta
l 
R1 40 95 -1,85 0,07 63 118 -0,41 0,68 55 160 -0,90 0,37 
R2 65 120 -0,30 0,77 59 164 -0,69 0,49 57 162 -0,80 0,42 
R3 56 111 -0,86 0,39 63 168 -0,42 0,68 52 157 -1,10 0,27 
R4 64 169 -0,37 0,71 65 120 -0,30 0,77 62 167 -0,48 0,63 
R5 61 166 -0,57 0,57 46 101 -1,46 0,15 61 116 -0,59 0,55 
R6 66 121 -0,27 0,79 69 174 -0,06 0,95 39 144 -1,86 0,06 
R7 53 158 -1,00 0,32 49 154 -1,27 0,20 43 148 -1,64 0,10 
R8 40 95 -1,82 0,07 60 115 -0,62 0,53 70 125 0.00 1,00 
R9 49 154 -1,27 0,20 32 137 -2,25 0,03 28 133 -2,52 0,01 
P
ro
fi
le
 
R1 61 166 -0,53 0,60 40 145 -1,79 0,07 44 149 -1,53 0,13 
R2 68 123 -0,15 0,88 57 162 -0,80 0,43 64 169 -0,35 0,72 
R3 36 141 -2,01 0,04 41 146 -1,71 0,09 41 146 -1,75 0,08 
R4 62 117 -0,52 0,61 50 155 -1,20 0,23 58 113 -0,75 0,45 
R5 70 125 0.00 1,00 54 159 -0,98 0,33 49 154 -1,29 0,20 
R6 51 106 -1,13 0,26 70 175 -0,03 0,98 46 151 -1,45 0,15 
R7 69 174 -0,09 0,93 50 155 -1,18 0,24 64 169 -0,35 0,72 
R8 44 149 -1,56 0,12 49 154 -1,27 0,20 48 153 -1,35 0,18 
R9 62 117 -0,47 0,64 68 123 -0,15 0,88 65 170 -0,33 0,75 
R10 55 160 -0,92 0,36 51 106 -1,13 0,26 50 155 -1,18 0,24 
 
